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ABSTRACT
The role of genotype in Saccharomyces cerevisiae resistance to 4methylcyclohexanemethanol
Michael C. Ayers
The chemical 4-methylcyclohexanemethanol (MCHM) spilled in the Elk River near
Charleston, WV in January 2014, impacting the drinking water of 300,000 residents. Initial
studies on MCHM following the spill attempted to characterize its toxicological effects in
animals, but largely ignored characterization of its effects on cellular pathways and metabolism.
In this study, I used this chemical as a novel stressor for the model eukaryote S. cerevisiae to
explore the relationship of genotype and stress phenotypes. Initial exploration characterized
the stress phenotype of MCHM in yeast through growth assays, cell cycle analysis, and
transcriptomic data. MCHM exposure caused cells to arrest growth in G1, activating a well
characterized yeast process called the environmental stress response. Further exploration was
carried out using a genetic screen of approximately 5000 haploid gene knockout strains, which
combined with the transcriptomic data, revealed that the causes of the stress response in yeast
were nutrient deprivation related to amino acid biosynthesis and reactive oxygen species
production. A QTL analysis of standing variation between two parental strains with variable
resistance uncovered the role of zinc homeostasis and its interaction with the hydrotrope
chemical properties of MCHM in protein aggregation as a contributor to resistant phenotypes.
Finally, an In-Lab evolution study to produce resistant strains for variant analysis showed
mutations in the pleiotropic drug response transcription factor PDR3 cause a reproducible
induction of MCHM resistance. These studies combined to characterize cellular changes from
MCHM, identify genes required for tolerance, and explore both standing and evolved variation
in genotypes that contribute to and produce an MCHM resistant phenotype.
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CHAPTER 1: OBJECTIVES AND OVERVIEW
The relationship between genotypes and phenotypes is central to modern genetics
research. Variations in DNA sequence produce variations in phenotypes. Whether the variation
results in an alternatively active protein, an inactive protein, or a differentially expressed gene
product, changes in sequence can have dramatic effects on an organism’s traits. Stress
phenotypes, such as loss of viability, cell cycle arrest, DNA damage, and transcriptome
reprogramming are studied in yeast to analyze both the toxic effects of stressors and the roles
of gene and protein networks in responses. Drugs such as hydroxyurea, identified by screens in
the 1960s to have anti-tumor properties and subsequently used to treat diseases such as
cancers and sickle cell anemia, have also become useful as sources of chemical stress in cellular
biology research (reviewed in Singh & Xu, 2016). For instance, the reversible inhibition of DNA
replication by hydroxyurea allows researchers to arrest cells in S phase and study synchronized
cell populations. It also damages DNA and causes oxidative stress, so it is used in the study of
stress responses and DNA damage repair mechanisms (reviewed in Singh & Xu, 2016). As with
much cellular biology research, studying chemical stress phenotypes can impact seemingly
unrelated areas of research by revealing intertwined networks of proteins and metabolism in
the cell.
The chemical 4-methylcyclohexanemethanol (MCHM) is used in industrial processes to
clean coal, and it is most well-known from a spill into the Elk River in January 2014 where it
contaminated the drinking water of 300,000 residents in the Charleston, WV area. In the
months following the spill, the National Toxicology Program (NTP) embarked on a testing
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strategy to determine the potential toxicological dangers of the chemical. Most of the effects
the NTP identified were found only at levels 100 or more times higher than those detected
from the spill. The most concerning effect was on developmental phenotypes, specifically low
fetal birth weight and skeletal abnormalities in rodents (West Virginia Chemical Spill: Collective
NTP Findings and Supporting Files, n.d.). Another biological study identified photomotor
response changes in zebrafish possibly indicative of neurotoxic effects (Horzmann et al., 2017).
Almost no analysis of cellular and molecular changes that occur with MCHM treatment was
performed. The NTP studied minimum dosages required to exhibit gene expression changes in
rodent kidney and liver cells, approximately 50 times higher than a 1ppm screening level set by
the CDC after the spill (West Virginia Chemical Spill: Collective NTP Findings and Supporting
Files, n.d.). Another study looked at the expression of a subset of 148 stress proteins in yeast
with treatment by MCHM, which found that there was increased expression of chemical stress
and protein stress proteins, and DNA damage and oxidative stress in cotreatment of MCHM and
a liver extract additive intended to produce MCHM metabolites (Lan et al., 2015). While
toxicological outcomes were relatively well studied after the spill, there was very little study of
the cellular effects of MCHM prior to this dissertation.
The purpose of the research in this dissertation was to study the genetics of chemical
stresses in yeast by using the toxicologically important MCHM. The main goal of this research
was to identify genetic underpinnings of MCHM resistant phenotypes. Initial work characterized
the phenotypes of MCHM treatment using growth assays and viability assays. I put forth the
following specific aims to explore the genotypes that produced MCHM tolerance in yeast.
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Specific Aim 1: Explore the effects of MCHM on eukaryotic cells by identifying stress
phenotypes and the genes required for resistance in S. cerevisiae. I characterized the effect of
MCHM on the growth of yeast, using viability and cell cycle analysis to determine that the
chemical arrests cells in G1 to inhibit growth, as opposed to killing cells outright. We also used a
transcriptomic dataset to characterize the cellular response phenotype as the programmed
yeast environmental stress response. I utilized a genetic screen of nearly 5000 single gene
knockouts to get an unbiased analysis of required genes for MCHM resistance. Elucidating the
types of stress phenotypes of the cells with these two genomic datasets, we performed followup assays to characterize and confirm the nutrient, oxidative, and DNA damage stresses that
were seen.
Specific Aim 2: Understand the role of existing genetic variation in resistance to MCHM using
two strains with variable resistance phenotypes. I used a segregant collection of 125 haploid
offspring of two parental strains with variable resistance to MCHM to perform a QTL on growth
in rich liquid media containing MCHM. While variation being spread relatively evenly across the
genome seemed was evident, one peak was significant. I used knockouts in multiple strains to
narrow down the peak to a zinc transporter gene and confirmed the importance of zinc with
supplementation. We combined this data with the analysis of metal ion transporter changes in
the transcriptome and changing levels of iron and zinc in MCHM treated yeast to further
characterize the role of zinc and metal homeostasis in response to MCHM. This work was
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combined with transcriptomics and protein aggregation experiments performed by
collaborators to explore the interaction between MCHM and zinc in resistance.
Specific Aim 3: Examine adaptation in the production of resistance to MCHM through
production of new genetic variation. I treated multiple replicates of the sensitive yeast parent
from the QTL strains in Aim 2 with MCHM in rich liquid media until resistance developed.
Variant analysis was performed to identify the mutations that appeared during the adaptation
to MCHM. Variants from control evolution replicates in liquid media without MCHM were used
to eliminate regions that accumulate mutations unimportant for resistance to MCHM. Genes
containing coding variants unique to the resistant strains were analyzed for shared functions. I
filtered any genes that mutated often in resistant strains but rarely in control strains. One gene
mutated in every resistant strain, producing mutant alleles including single amino acid changes
and large C-terminal truncations due to early stops. I then initiated follow-up functional
genetics on this pleiotropic drug response transcription factor to determine if mutations in the
parent strain and other genetic backgrounds were sufficient to induce resistance.
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Chapter 2: Introduction

Genotypic and phenotypic diversity in yeast:
Saccharomyces cerevisiae is a key eukaryotic model organism for research into cellular
function and genomics precisely because it is a diverse species. It has a genome size of
approximately 12Mb containing around 6000 genes, yet routinely any two strains may be as
variable as 60,000 to 100,000 SNPs and hundreds or thousands of indels (Engel & Cherry, 2013).
This genotypic diversity is accompanied by a similarly diverse range of phenotypes. Researchers
often explore or exploit phenotypic diversity in culture growth, colony size and morphology,
high and low temperature growth, nutrient utilization, chemical and drug resistance, and other
cellular traits in yeast strains (J. E. G. Gallagher et al., 2014; Liti et al., 2009; Steinmetz et al.,
2002; Strope et al., 2015). The results of such studies inform upon the roles of individual genes
within the cell, but also how these genes and the proteins for which they encode form
pathways and interrelated networks that create phenotypes and characteristics at the
organismal and community level.
Yeast is a useful model to explore relationships between genotype and phenotypes such
as resistance to various chemicals. Experiments on specific chemicals do not only reveal the
genetic and protein network basis of the resistance to single chemicals. They often reveal how
identified gene and protein networks work together in cellular functions. Cellular pathways
such as DNA replication or cell cycle analysis through synchronization can be explored through
studying stress from chemicals like hydroxyurea (Singh & Xu, 2016). It is sometimes only
through stressful perturbations to the cell that processes and mechanisms can be revealed.
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Previous and continuing work of our group studies several chemical perturbations in yeast cells,
including copper, 4-Nitroquinolone-1-oxide (4NQO), glyphosate-based herbicides, and MCHM
(J. E. G. Gallagher et al., 2014; Ravishankar, Cumming, et al., 2020; Ravishankar, Pupo, et al.,
2020; Xiaoqing Rong-Mullins, Ravishankar, et al., 2017; Xiaoqing Rong-Mullins, Winans, et al.,
2017; Xiaqing Rong-Mullins et al., 2017; Winans & Gallagher, 2020).
One of the major ways that resistance to these chemicals can be explored is by
exploiting the natural genetic variation in different yeast strains. It is efficient to perform
growth assays of these strains in the presence of the chemical to elucidate phenotypic variation
in resistance. The resistant and sensitive strains can then be analyzed for the underlying genetic
differences behind the phenotypes. For instance, if yeast strain YJM789 is resistant to the
chemical 4NQO while strain S288c is sensitive, a collection of haploid progeny of these two
parent strains with sufficient segregating markers can be used to perform a quantitative trait
locus (QTL) analysis of the resistant phenotype. Indeed, such an analysis, showing the
association of a genome locus and the resistant phenotype, revealed that the resistance to
4NQO observed in the YJM789 strain versus the S288c strain maps to a gene called YRR1 (J. E.
G. Gallagher et al., 2014). Further analysis of this strain using genetic manipulations to swap
alleles of YRR1 between the strains allowed for confirmation of this genotype-phenotype
relationship. The segregant collection used in this YRR1 study was also used for a glyphosatebased herbicide study that found mapped resistance to variation in the genes DIP5 and PDR5 in
these strains. QTL mapping of this collection was used in the studies of this dissertation. The
ease of these types of manipulations in yeast allows for unique opportunities for functional
genomics.
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Other ways that genotypes related to resistance phenotypes can be explored are
through laboratory evolution and genetic screen experiments. Yeast as a model organism for
genetics research benefits from decades of community resources, including a collection of
strains with systematically knocked out ORFs of each of the genome’s nearly 5000 nonessential
genes (Giaever et al., 2002; Giaever & Nislow, 2014). With each gene knocked out, it is possible
to screen for the requirement of each one for any number of phenotypes, including resistance
to a chemical. This functional genomics approach of screening the entirety of the yeast
knockout collection resulted in functional annotations to thousands of proteins (reviewed in
Giaever & Nislow, 2014). Laboratory evolution experiments exploit the ability to quickly evolve
yeast strains using their short generation time of approximately 90 minutes in liquid culture to
produce strains with a resistant phenotype. Sequencing to determine variants in the resistant
strains then allows researchers to test which genotypes are sufficient to produce the
phenotype. Evolving yeast in glyphosate-based herbicides revealed copy number variation in
genes related to cell wall stability, mitochondrial function, and sterol content that were likely
responsible for resistance to additives in the herbicide besides glyphosate (Ravishankar, Pupo,
et al., 2020). Both genetic screening of the knockout collection and In-Lab evolutions were used
in this dissertation to explore the relationship of genotype to MCHM resistance in yeast.
The Elk River Spill chemical MCHM:
The chemical MCHM was a previously little-studied chemical involved in the processing
of coal, until a rusted storage tank resulted in a spill of approximately 10,000 gallons of crude
MCHM into the Elk River near Charleston, WV on January 9th, 2014. This spill interrupted the
water supply of approximately 300,000 residents. Research on MCHM since the Elk River spill
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increased over concerns about the little characterized physical and biological properties of this
chemical. In the immediate aftermath of the spill, the chemical was detectable in homes due to
its intense and distinct licorice smell. MCHM consists of a cyclohexane ring with a methanol
group directly opposite a methyl group on the ring structure. The methyl and methanol groups
allow for both cis and trans isomers. The trans isomer of MCHM was found to be detectable
due to this smell at approximately 0.06ppb in the air (D. L. Gallagher et al., 2015). Residents
reported skin, respiratory, and gastrointestinal issues to poison control and healthcare
providers that cleared up without medical intervention (Thomasson et al., 2017). The levels of
MCHM at the water intake of the treatment plant for these residents showed levels around
2ppm several days after the spill (Weidhaas et al., 2017). The estimated potential max exposure
delivered to homes was approximately 2.6ppm (Weidhaas et al., 2017), and by the January 27th
one study detected levels in tap samples of only around 0.15ppm that continued dropping
(Foreman et al., 2015). A study conducted well after the spill evaluated the effect of activated
carbon on remediation of the chemical in a treatment plant scenario and found it to be the best
option as compared to permanganate or chlorine treatment. However, unexpectedly high levels
of the activated carbon would have been needed to reach CDC screening levels of 1ppm
(Weidhaas et al., 2017). In contrast to chemical water treatment strategies, several studies
found that there would potentially have been significant bioremediation from bacterial sources
in sediments accumulating the chemical from contact with the water from the spill (Cozzarelli
et al., 2017; Yuan et al., 2016b, 2016a).
MCHM toxicological work in broad species:
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The National Toxicology Program, part of the U.S. Dept. of Health and Human Services,
was nominated by the Centers for Disease Control to perform a battery of studies on MCHM in
the immediate aftermath of the spill (West Virginia Chemical Spill: Collective NTP Findings and
Supporting Files, n.d.). As a chemical with little previous characterization for its effects on
biological systems, it was important to run detailed assessments from toxicity in organisms
from bacteria to metazoan, to developmental effects on model organism embryos and fetuses.
The major goal of the studies was to evaluate whether the screening levels of MCHM in the
drinking water imposed by the CDC at the time of the spill, 1ppm, were appropriate to protect
the health of the community (West Virginia Chemical Spill: Collective NTP Findings and
Supporting Files, n.d.). NTP designed studies to explore developmental toxicity in rats, fish, and
worms, dermatologic sensitivity in mice, motor responses indicative of neurological toxicity in
fish, and mutagenic effects on the DNA of bacteria and rat blood cells (West Virginia Chemical
Spill: Collective NTP Findings and Supporting Files, n.d.). This covered the major concerns of
toxicological effects on humans coming into contact with MCHM through the Elk River spill,
specifically sensitization to the chemical, a worry due to self-reported rashes among residents
following the spill, and developmental and neurotoxic effects, a worry for pregnant women and
their children born in the aftermath of the spill (Benson et al., 2018; Johnson et al., 2017;
Monnot et al., 2017; West Virginia Chemical Spill: Collective NTP Findings and Supporting Files,
n.d.).
The NTP studies on dermatologic sensitization and irritation in mice and rats did show
an effect of sensitivity, but at concentrations much higher, on the order of 100,000 fold higher,
than the levels the CDC set for screening in the aftermath of the spill (West Virginia Chemical
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Spill: Collective NTP Findings and Supporting Files, n.d.). The analysis of a photomotor assay
response in zebrafish, potentially indicative of neurotoxicity, saw an effect at 11ppm of MCHM,
approximately 10 times above the CDC levels for water screening (West Virginia Chemical Spill:
Collective NTP Findings and Supporting Files, n.d.). This activity was in agreement with the
results of zebrafish work by another lab that detected alterations in motor responses due to
MCHM at between 1 and 25ppm (Horzmann et al., 2017). These responses were at relatively
low dosages compared to the minimum dosages found for other assay effects. NTP assays for
DNA mutagenicity in both bacteria and rat red blood cells detected no DNA damage. An early
yeast study from an outside lab did find evidence that potential metabolites of MCHM from
cotreating yeast and a human cell line with MCHM and S9 liver extract increase expression of
markers related to DNA damage, such as Rad51, a protein involved in repairing DNA double
strand breaks (Lan et al., 2015). The only molecular assays done by the NTP studies was an
expression analysis to determine minimum dosages of MCHM to induce gene expression
changes in liver and kidney of treated rats, presumably a proxy for detection of and attempted
adaptation to the stressor. This assay showed that levels approximately 50 times higher than
the CDC screening level of 1ppm was required to induce changes in liver gene expression, and
kidney gene expression did not change (West Virginia Chemical Spill: Collective NTP Findings
and Supporting Files, n.d.).
The most significant finding of the toxicological assessment, according to the NTP, was a
study of developmental toxicity in rats. There was a drop in fetal weight corresponding to a
200mg/kg dose, and significant skeletal deformations of the developing fetus at 400mg/kg
dose. These dosages were calculated to be over 1000 fold higher than any expected exposures
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of pregnant woman living in the vicinity of the Elk River spill, but the NTP ordered follow-up
analyses of birth weight outcomes for the region in response to this finding (West Virginia
Chemical Spill: Collective NTP Findings and Supporting Files, n.d.). The findings of this study did
not show any association between adverse birth outcomes, such as decreased birth weight and
APGAR scores, for those mothers who may have been exposed to the Elk River spill (Benson et
al., 2018). Despite most evidence leading to estimates of little effect of the Elk River spill on
health outcomes, this is due to the relatively low dosages of MCHM that was found in the spill.
The findings by the NTP and other labs of developmental changes, motor response changes,
and DNA damage stress, make further study of this chemical warranted.
MCHM studies in yeast:
Using yeast as a model for studying MCHM effects on cellular processes also began in
the aftermath of the Elk River spill. These studies were more focused on characterizing how the
chemical produces stress in the cell instead of focusing on toxicological outcomes such as
potential for mortality or developmental effects on organisms. The earliest study in yeast was
an expression study of a subset of yeast stress proteins tagged with GFP that exposed yeast and
a human cell line to MCHM, as well as MCHM + S9, an extract from liver that is intended to
provide insight into metabolites of chemicals with which it is cotreated (Lan et al., 2015). This
study showed that MCHM increased expression of stress response proteins from their curated
collection of proteins known to be important for stress response. Chemical stress and protein
stress proteins were upregulated with MCHM alone, and oxidative stress response proteins
were upregulated with the MCHM + S9 treatment (Lan et al., 2015). As stated previously, DNA
damage response proteins such as Rad51 were also upregulated (Lan et al., 2015). This study
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was designed to use a stress response collection of GFP tagged proteins, so it was biased to
study this subset of 148 proteins from the yeast proteome, out of a genome containing
approximately 6000 genes.
Other work in yeast includes the studies of the Gallagher Lab performed concurrently
with this dissertation. One study evaluated the metabolome of yeast treated with MCHM by
ESI-MS and GC-MS to characterize how MCHM affects yeast metabolism (Pupo et al., 2019).
The analysis of polar metabolites found an accumulation of amino acids in the cell that
indicates an effect on their production or their depletion through protein production (Pupo et
al., 2019). Transcriptomics in the same study pointed to both reduced expression of ribosomal
proteins and amino acid biosynthetic gene upregulation, evidence for these causes of amino
acid accumulation (Pupo et al., 2019). The nonpolar metabolites found reduction of several
phospholipids, such as phosphatidylinositol, that would impact the biophysical properties of
membranes in the cell (Pupo et al., 2019). These results agree with and support work presented
in this dissertation that describe stress responses in yeast in response to MCHM and MCHM’s
ability to act as a hydrotrope. The other study conducted by the Gallagher Lab evaluated the
effects of the polymorphic polyQ tracts of the Mediator Complex tail protein Med15 on
responses to stressors, including MCHM (J. E. G. Gallagher et al., 2020). Genetic variation in this
transcription factor, expressed from plasmids, affected the tolerance of MCHM in the same
genetic background (J. E. G. Gallagher et al., 2020). This was suggested possibly to be due to the
hydrotropic nature of MCHM and the way in which the polymorphic polyQ tracts of the Med15
proteins interact to form protein folding aggregations (J. E. G. Gallagher et al., 2020). The
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transcriptomic dataset from this study, analyzed by Amaury Pupo, appears with further
downstream analysis by me in the work of this dissertation.
Conclusion:
The work in these studies combines with the studies presented in this dissertation to
explore MCHM as a novel stressor of yeast. The work in this dissertation incorporates new
genomic datasets and new analyses of existing datasets from earlier studies to characterize the
role of genotype in MCHM resistance phenotypes. My work shows that MCHM activates the
yeast environmental stress response due to its impacts on nutrient pathways, oxidative stress,
metal metabolism, and DNA damage. Genetic variation in a metal homeostatic gene was
associated with MCHM resistance, though this phenotype is mostly controlled by small effect
loci throughout the genome. Despite the small effects of existing variation, mutations affecting
the protein sequence of the one of the transcriptional regulators of drug transporter genes
provided a reproducible path for evolved resistance. This work expanded the understanding of
MCHM stress phenotypes by focusing on cellular changes. It is also the first to examine the
genotypes controlling these phenotypes. The insights from these stress responses are useful to
the broader field of yeast stress genetics and the toxicological questions that remain
unanswered about this industrial spill chemical.
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Abstract
In 2014, the coal cleaning chemical 4-methylcyclohexane methanol (MCHM) spilled into
the water supply for 300,000 West Virginians. Initial toxicology tests showed relatively mild
results, but the underlying effects on cellular biology were underexplored. Treated wildtype
yeast cells grew poorly, but there was only a small decrease in cell viability. Cell cycle analysis
revealed an absence of cells in S phase within thirty minutes of treatment. Cells accumulated in
G1 over a six-hour time course, indicating arrest instead of death. A genetic screen of the
haploid knockout collection revealed 329 high confidence genes required for optimal growth in
MCHM. These genes encode three major cell processes: mitochondrial gene
expression/translation, the vacuolar ATPase, and aromatic amino acid biosynthesis. The
transcriptome showed an upregulation of pleiotropic drug response genes and amino acid
biosynthetic genes and downregulation in ribosome biosynthesis. Analysis of these datasets
pointed to environmental stress response activation upon treatment. Overlap in datasets
included the aromatic amino acid genes ARO1, ARO3, and four of the five TRP genes. This
implicated nutrient deprivation as the signal for stress response. Excess supplementation of
nutrients and amino acids did not improve growth on MCHM, so the source of nutrient
deprivation signal is still unclear. Reactive oxygen species and DNA damage were directly
detected with MCHM treatment, but timepoints showed these accumulated slower than cells
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arrested. We propose that wildtype cells arrest from nutrient deprivation and survive,
accumulating oxidative damage through the implementation of robust environmental stress
responses.
Introduction
The chemical 4-methylcyclohexane methanol (MCHM) was a previously little-studied
chemical involved in the processing of coal, until a rusted storage tank resulted in a spill of
crude MCHM into the Elk River near Charleston, WV. The spill’s size and location adjacent to a
drinking water treatment intake were sufficient to fill homes with an overpowering odor that
left many fearful of health consequences (Thomasson et al., 2017). This spill interrupted the
water supply of approximately 300,000 residents. Research on MCHM since the Elk River spill
has increased dramatically over concerns about the lack of characterized physical and biological
properties of this chemical (Weidhaas et al., 2016). For instance, an improved toxicological
study on MCHM’s effect on model organism viability has been performed (West Virginia
Chemical Spill: Collective NTP Findings and Supporting Files, n.d.), as well as one study on the
potential stress responses it may produce in yeast (Lan et al., 2015). However, these studies
had a focus on a few specific toxicological outcomes and predetermined stress pathways that
may miss other cellular changes. Recently, research has been begun to identify the biochemical
and transcriptional changes that MCHM may produce in organisms (Pupo, Ayers, et al., 2019;
Pupo, Ku, et al., 2019).
The environmental stress response (ESR) is a shared transcriptional response to multiple
stressors, including heat shock, osmotic shock, and hydrogen peroxide treatment, among
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others (Gasch et al., 2000). The role of paralogous transcription factors Msn2 and Msn4 are
important for a large portion of the ESR transcriptional induction (Gorner et al., 1998; MartínezPastor et al., 1996). The transcriptional programming of the environmental stress response
incorporates signals from diverse stress pathways including nutrient starvation (TOR),
osmolarity stress (HOG), and others, into the Msn2/4 transcriptional activators (Capaldi et al.,
2008; De Wever et al., 2005; Garmendia-Torres et al., 2007; Gorner et al., 1998; Gutin et al.,
2015; Santhanam et al., 2004). Implementation of the stress response involves two waves of
Msn2/4 import to the nucleus that modulate the initial intensity and prolonged duration of the
response (Gutin et al., 2019). The signaling kinase Mck1 is indispensable for the prolonged
response requiring the second import of active Msn2/4 to the nucleus (Gutin et al., 2019),
although it is unclear how the signal is maintained as there does not appear to be direct Mck1
interaction with Msn2 (Hirata et al., 2002). The karyopherin Msn5 involved in nuclear import
and export activity is important to maintain the prolonged stress response activity of Msn2/4 in
the ESR, apparently through the export of initial wave Msn2 from the nucleus, allowing for the
second wave of transcriptional activators to function (Gutin et al., 2019).
Amino acid biosynthesis is predominately regulated by the general amino acid
transcriptional activator Gcn4. Under amino acid starvation, the levels of Gcn4 increase due to
the decreased degradation and increased translation of the protein (reviewed in Hinnebusch,
1997; Meimoun et al., 2000). Gcn4 binds to a consensus promoter sequence upstream of many
of the amino acid biosynthetic genes to positively regulate their expression (Arndt & Fink, 1986;
Hill et al., 1986; Oliphant et al., 1989). This amino acid transcriptional control includes the
aromatic amino acid biosynthetic gene ARO3 and the specific tryptophan biosynthetic genes
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TRP2, TRP3, TRP4, and TRP5 (Braus, 1991). Tryptophan has been implicated for roles in stress
tolerances other than nutrient starvation. SDS sensitivity, a cell wall and plasma membrane
integrity stress that involves Mck1 effectors in yeast, is dependent on tryptophan biosynthesis
and levels of tryptophan and tyrosine in the media and cell (Schroeder & Ikui, 2019).
Tryptophan biosynthetic mutants, trp1-5, were also reported in a special warning for their use
as auxotrophic markers in yeast genetics due to an aberrant sensitivity to many stressors
including rapamycin, high pH, and several metal cations (González et al., 2008). A more recent
report has shown that tryptophan depletion due to a combination of transporter dysfunction at
low temperature and trp1-5 mutants also confers sensitivity to the DNA damaging agents MMS
and HU (Godin et al., 2016). The role of the aromatic amino acids and their biosynthetic
pathways in stress tolerance other than nutrient starvation is not fully understood, but it is well
established.
Reactive oxygen species (ROS) have previously been implicated as a source of toxicity in
cells treated with MCHM (Lan et al., 2015). Cells contain conserved robust networks to mitigate
the toxic effects of ROS. These include various proteins, from enzymes that detoxify the
reactive species directly, to proteins that repair damage within the cell, such as to DNA (Ayer et
al., 2014). The thioredoxin and glutathione (GSH) pathways have significant roles in the cell’s
response to ROS. They perform overlapping functions reducing thiol oxidation that can damage
proteins in the cytosol. Furthermore, GSH has roles in iron homeostasis between the
mitochondria and vacuole, and potentially as a possible buffer for oxidation in disulfide bond
formation during protein folding in the ER (Cuozzo & Kaiser, 1999; reviewed by Toledano et al.,
2013). Mitochondria serve as a major producer of ROS in the cell as oxidative phosphorylation
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leaks electrons to molecular oxygen to produce superoxide anions, so these pathways are
activated by normal cellular metabolism (reviewed by all the following, Ayer et al., 2014;
Perrone et al., 2008; Temple et al., 2005). However, they also become important during the
response to toxic chemicals, which can produce ROS directly, or else indirectly through
metabolism and attempted detoxification in the vacuole. Toxicity of chemicals that produce
ROS in the cell may be mitigated through treatment with antioxidants or intensified through
damage to the cellular stress networks (Couto et al., 2016; Sekito et al., 2014).
Much of a yeast cell’s response to stress involves the vacuole (Li & Kane, 2010). This
organelle serves as a site for various processes of degradation, detoxification, and metal ion
and pH homeostasis (Li & Kane, 2010). The vacuolar ATPase (v-ATPase) is a structure in yeast
that is highly conserved and has been adapted to perform a wide range of functions in various
eukaryotes. In many animals, including Drosophila, homologs of the v-ATPase are known to
contribute to nerve function via vesicular excretion of neurotransmitters in animals including
humans (Hiesinger et al., 2005). In yeast, the v-ATPase is responsible for acidifying the vacuole
interior, creating a proton gradient that is responsible for multiple homeostatic processes
(reviewed by the following, N. Nelson & Harvey, 1999; Nishi & Forgac, 2002). As such, its effects
on metal ion transport and vacuolar acidification result in a set of knockout phenotypes for
many of the v-ATPase’s subunits (Hemenway et al., 1995; H. Nelson & Nelson, 1990; Ohya et al.,
1991; Sambade et al., 2005). This vma- phenotype includes sensitivities to metal ions, reactive
oxygen species, and pH perturbations in either direction. Inositol depletion through mutation or
chemical treatment negatively impacts the assembly and activity of the v-ATPase in yeast

25

(Deranieh et al., 2015; Ohya et al., 1991). Any chemical that can inhibit or damage the v-ATPase
would likely have distinct consequences for the cell’s ability to cope with other stresses.
The goal of this study was to characterize the response of yeast cells to the foreign
chemical MCHM. Treatment of yeast with MCHM created pleiotropic effects on networks
throughout the cell. We employed methods including viability assays, RNAseq, flow cytometry,
and a genetic screen of knockout strains to characterize these effects. We found several
expected changes to networks, such as the pleiotropic drug response ABC transporters that
remove xenobiotics from the cell. Our data show direct evidence of ROS and DNA damage
following MCHM treatment. The stress also revealed a role for the aromatic amino acid
biosynthetic pathway outside nutrient availability for the response to this particular stressor.
Any toxicity that these cellular changes caused did not result in large changes in cellular viability
but instead resulted in the arrest of the cell cycle in G1. Effects on the cell were wide-ranging,
but wildtype cells were able to implement the ESR to recover from exposure at levels higher
than spill levels.
Materials and Methods:
Yeast strains and media:
The haploid BY4741 strain (MATA, his3Δ, leu2Δ, ura3Δ, met15Δ) (Brachmann et al.,
1998) and its MATalpha counterpart BY4742 (his3Δ, leu2Δ, ura3Δ, lys2Δ), were used for the
majority of experiments as denoted. RNAseq, viability, growth, comet and flow cytometry
assays used the BY4741 strain. The genetic screen used the BY4742 collection (Giaever et al.,
2002). The YJM789 wildtype strain (MATalpha, lys2) and its previously generated aro1
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knockout (MATa, ARO1::NATR)(Rong-Mullins, Ravishankar, et al., 2017) were used in serial
dilution growth assays only as shown. Rich media containing 1% yeast extract, 2% peptone, and
2% dextrose (YPD) or minimal media containing 0.67% yeast nitrogen base and 2% dextrose
(YM) with histidine, leucine, uracil, and methionine supplementation for BY4741 strains were
used in the various experiments as indicated. Experiments where the aromatic amino acids
were supplemented in excess to YPD media were done to a final concentration of 0.02mg/mL
tryptophan, 0.03mg/mL tyrosine, and 0.05mg/mL phenylalanine. The strains used in the TAT2
overexpression serial dilution assay were created by transforming BY4742 yeast with either
pRS315 (CEN, LEU2) plasmid (Sikorski & Hieter, 1989) or commercially available LEU2+
multicopy yeast genomic tiling collection plasmids containing genomic regions from
chromosome XV corresponding to the region surrounding the TAT2 ORF (Jones et al., 2008).
Supplementations of MCHM, drugs, or other nutrients were added to YPD or YM media as
indicated for each experiment. MCHM for experiments is the same crude MCHM formulation
that made up the primary chemical presence in the Elk River spill. This formulation is
approximately 89% 4-methylcyclohexane methanol, with other cyclohexanes making up the
rest of the material was obtained directly from the manufacturer, Eastman Chemical Copmany
(Kingsport, TN, US). All concentrations of MCHM indicated in figures are in ppm of crude MCHM
formulation, so all conclusions are for this formulation, not pure MCHM.
Growth and viability assays:
Growth and viability assays were performed as previously described (Rong-Mullins,
Winans, et al., 2017). Plating for growth assays was only done at a maximum of five strains per
plate to keep cells in the central portion of the plate, due to noticed position effects on toxicity,
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likely from evaporation, a known and observed characteristic of MCHM being its volatility
(Phetxumphou et al., 2016; Sain et al., 2015). Furthermore, plates were used within a day to
minimize any evaporation of MCHM from the media that would affect concentrations.
Concentrations are noted in figure legends. When glutathione was used to attempt to rescue
sensitive phenotypes, the concentration on plates was 10mM or 100mM, as noted. Oxidized
glutathione was used at a concentration of 5mM corresponding to its structure as a dimer of
glutathione. Ammonium sulfate was supplemented at a concentration of 10mM. Viability
assays were carried out for 1.5 to 24 hours while kept in log-phase for concentrations indicated
in figures.
Flow cytometry:
BY4741 cells were grown to saturation overnight and returned to mid-log phase. Cells
were then diluted to a starting OD600 of 0.3 in biological triplicate in YPD media containing
550ppm MCHM. Cells were then harvested at the indicated time. Timepoints longer than 90
minutes required dilutions into fresh treatment media two times over the 12-hour experiment
to maintain log-phase. The harvesting procedure involved taking 3mL of culture and fixing and
preparing cells as previously published (Haase & Reed, 2002). For cell cycle analysis, cell pellets
were fixed in 70% ethanol overnight at 4⁰C. Fixed cells were pelleted and resuspended in 0.5mL
of a 2mg/mL RNAse A solution (50mM Tris pH 8.0, 15mM NaCl boiled for 15 minutes and cooled
to room temperature) for a 12-hour incubation at 37⁰C. Cells were then incubated in 0.2mL of a
protease solution (5mg/mL pepsin, 4.5µl/mL HCl) for 20 minutes at 37⁰C. Finally, samples were
stored in 0.5mL of 50mM Tris pH 7.5 at 4⁰C for up to a week before undergoing flow cytometric
analysis. Immediately prior to flow cytometry, samples were shortly sonicated at low power on
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a Branson model SSE-1 Sonifier for six intervals of one-second bursts, and 50µl of each sample
was suspended in 1µM SYTOX Green. Samples were analyzed on a BD LSRFortessa using a FITC
channel. Approximately 30,000 events were collected for analysis. FCS Express 5.0 software was
used to analyze the DNA content of cells using a multi-cycle DNA histogram and incorporated
DNA modeling Statistics. Models were compared via Chi-squared results and the SL S0 model
selected for determining the portion of the population in S phase for all samples. All replicates
and timepoints fell within good or fair confidence for cell cycle modeling and S phase
confidence of the model. The model produced the values for the proportions of the cell
population falling within the G1, S, and G2/M phases used for analysis.
For measurement of ROS, live cells were pelleted then suspended in 200μl of 50mM
DHE in phosphate-buffered saline (PBS). The dyed cultures were incubated at 30⁰C for 20
minutes and washed with PBS. A positive control sample of BY4741 cells was treated with
25mM H2O2 for 1.5 hours. The DHE dyed samples were then analyzed within 2 hours of
harvesting on a BD LSRFortessa using preset propidium iodide detection defaults.
Approximately 30,000 events were collected per sample for downstream analysis. A High ROS
subpopulation range was determined by gating events in downstream analysis at a DHE
fluorescence level of 350. This value gave all three biological BY4741 wildtype strain replicates
treated as the H2O2 positive controls approximately 95% of their cells falling above this value
(94.69% - 96.86% actual percentages of cells). The wildtype and vma3 cells, both untreated and
treated with MCHM, that fell above a fluorescence level of 350 were considered to be part of a
High ROS subpopulation. A one-tailed t-test was used to determine significance of increases in
subpopulation percentages for each strain.
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Genetic screen:
The genetic screen of the BY4742 haploid knockout collection was performed via the
phenotyping of serial dilution growth on solid media by adapting a previous screen technique
(Bae et al., 2017). In short, frozen 96-well microtiter plates of the knockout collection were
thawed and inoculated via pinning into 96-well growth chambers containing YPD in biological
triplicate. Chambers were grown at 30⁰C for 2 days until all wells were saturated. Each well was
then serially diluted into 96-well microtiter plates three times at 20-fold concentrations, for
three wells at 20-fold, 400-fold, and 8000-fold dilution from saturated. Diluted plates were then
pinned onto large YPD solid media plates with or without 300ppm MCHM. Plates were visually
scored for growth at 2-3 days, comparing control, and treated plates for each replicate.
Knockout strains showing decreased growth of at least one spot, unaccounted for by decreased
growth rate in general on control media, were recorded as screen “hits”. There was occasional
variability in growth between replicates, so knockouts that did not replicate sensitive in all
three trials filtered out.
RNAseq:
The transcriptomic dataset for this study was produced previously and published with
full raw data output and a partial analysis (Gallagher et al., 2020). The raw data are available at
GSE, accession number GSE129898
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129898). A partial reanalysis for this
paper included comparisons of specifically strains of the BY4741 untreated control and the
BY4741 MCHM treated cells. The library prep, transcript quantification with salmon (v0.9.1),
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bioinformatics pipeline, and differential analysis with DESeq2(1.18.1) were all performed
exactly as in the previous study (Gallagher et al., 2020). GO Term analysis was performed with
DAVID bioinformatic database as below for this study.
Comet Assay:
DNA damage resulting from MCHM exposure was quantitated using comet tails as
previously described (Azevedo et al., 2011; Oliveira & Johansson, 2012). After incubation in
MCHM for 30 minutes or hydrogen peroxide for 45 minutes (Heck et al., 2010; Rowe et al.,
2008) as a positive control, single cells were solidified in 1.5% low-melting agarose. The cell
walls were digested using 80 μl of 2mg/ ml zymolyase to create spheroplasts and immobilized
on a glass slide. After cells were then lysed with 10 mM Tris HCl pH 10, 30 mM NaOH, 1 M NaCl,
50 mM EDTA and 0.05% w/v laurylsarcosine, they were rinsed three times with TAE, and nucleic
acid was separated electrophoresis through the gel with 14V for 10 minutes. The gels were then
neutralized Tris-HCl pH 7.4, and subsequently fixed with 76% and then 96% ethanol solutions to
fix the DNA in place. DNA was stained with ethidium bromide for 20 minutes and then rinsed in
water. The DNA fragments formed a tail from the rest of the DNA that has remained intact (the
head). Images for each sample 17-42 ‘comets’ were captured with a Nikon A1R confocal
microscope and measured via pixel intensity and distance (μm) of the DNA migration through
the gel using TriTek CometScore 2.0.0.38. Statistical analysis was performed on tail length
measurements using a one-way ANOVA and Tukey’s HSD test in base package of R version 3.6.3
(aov and TukeyHSD commands).
GO Term analysis:
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The knockout screen gene list and the RNAseq differential analysis were each
analyzed further using the GO Term function of the DAVID bioinformatic database at
https://david.ncifcrf.gov (Huang et al., 2009a, 2009b). Default settings were used, and no
optional steps were included. Gene lists were searched for all three ontologies, though process
and function were determined to show the most informative results and included in the main
figures. Full results are available in supplemental files 1-3.
Data and Reagent availability statement
Raw data for transcriptome analysis are available at GSE, accession number GSE129898
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129898). GO Term analysis results
are available in supplemental files 1-3. The full gene lists of genetic screen hits, significantly
upregulated genes, and significantly downregulated genes are available as Tables S1-S3.
Haploid BY4741 and BY4742 knockout collection strains and YJM789 aro1 knockout are
available by request. The plasmids and/or resulting strains used in the TAT2 overexpression
analysis are available by request, or available commercially from DHARMACON. Crude MCHM
used as the main reagent in the experiments was a gift from the Eastman Chemical Company,
but a limited supply is available upon request.
Results
Determination of S. cerevisiae sensitivity to MCHM treatment.
S. cerevisiae were treated with a range of MCHM levels to determine minimal
concentrations that reduced growth in rich media (YPD). The levels were initially titrated, and
approximately 400ppm MCHM inhibited the growth of BY4741 yeast (Figure 1A). The
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concentrations used on yeast in these growth assays (400-600ppm, 2.8-4.2mM) were
approximately 100 times greater than the highest levels recorded in the water distribution
system of Kanawha County, WV when monitoring began the day after the spill (Whelton et al.,
2014). While the growth assay phenotype itself requires a relatively high dosage of the
chemical, the clear phenotype of decreased growth of yeast at this concentration is informative
to the design of experiments that exploit the many genomic resources of the yeast. Similar
chemical assays of toxic chemicals, such as hydrogen peroxide, use a comparable range of
doses (0.5-5mM) to exploit the yeast growth phenotype as a measurement for cellular changes,
including the original papers establishing the transcriptional programming of the yeast
environmental stress response (0.3mM H2O2)(Azevedo et al., 2011; Gasch et al., 2000).
Decreased growth of yeast treated with MCHM is not due to large-scale cell death.
To assess whether MCHM inhibited growth by decreasing cellular viability or by
arresting growth, acute and chronic viability assays were completed (Figure 1B). Mid-log phase
yeast were acutely exposed for 90 min and chronically exposed for 24 hours to the 550ppm
MCHM. Yeast were then washed and plated onto YPD with no MCHM. After growing plates for
two days, there was little if any reduction in colony-forming units with the YPD-MCHM treated
yeast.
To determine if the reduction in growth is due to cell cycle arrest, we analyzed MCHM
treated yeast by flow cytometry (Figure 1C-1F). Untreated cellular populations showed an
asynchronous pattern, for which each of the three phases had upwards of 20% of the total
cellular population (Figure 1C and 1D). However, within 30 minutes, the MCHM treated
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samples showed that less than 10% of the population was in S phase (Figure 1E and 1F). The
cells treated with MCHM appear to arrest almost immediately in G1 phase, leading to a nearly
instantaneous loss of S phase population as no new cells leave G1. Over the course of the 12hour experiment, the population in G2 also decreased to less than 10% of cells (Figure 1E and
1F). MCHM treated yeast failed to grow because they arrested in G1, not because of decreased
viability.
Genetic screen reveals cellular pathways and components required for MCHM tolerance
The cell cycle arrest of MCHM treated yeast was hypothesized to be attributable to
environmental stress response programming, as many stressors initiate arrest as the cells
attempt to ameliorate and recover from damage caused (Gasch et al., 2000). In order to test
this hypothesis, we collected genomic datasets to analyze which genes were functionally
required for MCHM tolerance in mutant strains and which were differentially expressed in
wildtype cells. The nearly 5000 strains of the haploid BY4742 knockout collection were tested
for growth phenotypes on 300ppm MCHM in a genetic screen (Supplemental Figure 1). The
results revealed that 329 genes were required for the tolerance to MCHM treatment
(Supplemental Table 1). Several individually important environmental stress response genes
were revealed by the screen. Two genes of note for their role in the control of Msn2/4regulated stress responses were MCK1 and MSN5. Deletions of these two genes have been
shown previously to affect the ability of Msn2 to control stress response programming (Gutin et
al., 2019).
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GO term analysis of the results of the screen pointed to mitochondrial translation as the
most enriched subset of yeast genes (Figure 2A). This particular GO term agrees well with
previously published data showing that petite yeast strains are sensitive to MCHM (Pupo,
Ayers, et al., 2019). Mitochondrial function is important for dealing with many stressors,
especially those involved in reactive oxygen species production. The next most enriched gene
subset was the components of the vacuolar ATPase (v-ATPase). This transporter maintains the
acidity of the vacuole by pumping H+ ions across the vacuolar membrane. The homeostatic
processes that use this ion gradient are evidence that MCHM may be causing ROS stress(N.
Nelson & Harvey, 1999; Nishi & Forgac, 2002).
The next most enriched GO terms were for amino acid biosynthesis, especially aromatic
amino acid biosynthesis. As the screen was performed on YPD media, it was surprising that
these biosynthetic genes, including early precursor producing enzymes (ARO1 and ARO3) and
nearly the entirety of the tryptophan biosynthetic pathway (TRP2-5), were required when
presumably excess amino acids were available from the media.
MCHM treatment significantly affects the transcription of large portions of the yeast genome.
Transcriptomic analysis of the BY4741 strain treated with MCHM also supported the
hypothesis that the environmental stress response was activated with exposure to MCHM.
There were 592 significantly upregulated genes in response to MCHM (Supplemental Table 2
and Figure 2B), while there were 576 genes significantly downregulated (Supplemental Table 3
and Figure 2C). These lists of genes were analyzed for GO terms and several of the terms were
consistent with the activation of the ESR (Figure 2B-C). The upregulated GO terms for drug
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export, autophagy, and mitophagy point to ESR mechanisms for the removal of toxic substances
from the cell and the reapportionment of cellular resources to overcome and adapt to a
stressor. The upregulated terms related to amino acid biosynthesis and mitochondrial function
(TCA cycle, iron ion homeostasis) were consistent with the genetic screen GO term analysis. The
mitochondrial overlap between the datasets is likely due to the importance of ROS stress
response, though the importance of the amino acid pathways as mentioned above, especially
considering the cells are growing in rich media, is unclear.
The clearest indication for the central role of ESR activation by MCHM exposure was the
downregulated GO terms. Ribosome biogenesis and related functions (other ribosomal terms
were also significant as seen in Supplemental Table 3 but omitted from the figure for legibility)
were the primary GO terms found in this dataset. They are also classic pathways downregulated
in the ESR (Gasch et al., 2000). Most ribosomal biogenesis protein genes are essential and do
not appear in the haploid knockout collection used in the genetic screen, with 81% of the 79
ribosomal protein genes essential for growth in standard conditions (Steffen et al., 2012).
Therefore, the transcriptomic data was necessary supporting evidence for ESR involvement in
MCHM response in combination with the stress gene and amino acid biosynthesis knockouts
appearing in the screen. Other terms from the downregulated genes, including fatty acid
biosynthesis and regulation of cell size, are also likely related to the observed cell cycle arrest
and the reapportionment of energy and resources required for overcoming stressors.
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Table 1: List of genes overlapping between the genetic screen and upregulated or
downregulated RNAseq results, as shown in Figure 2. Genes are organized, with subheadings,
to highlight functions relevant to environmental stress responses.
Overlap of Screen and Upregulated
Genes

Overlap of Screen and Downregulated
Genes

Aromatic Amino Acid Biosynthesis:

Aromatic Amino Acid Synthesis/Transport:

ARO1

PRS1

ARO3

PRS3

TRP2

TAT1

TRP3
TRP4

RNA Processing/Ribosome Biogenesis:

TRP5

MRT4
NRS1

Amino Acid Biosynthesis:

RNR1

ILV6

RPA1

LYS2

TSR2

MET22
Translation:
Mitochondrial Localization:

BUD27

GGC1

FUN12

POS5
TGL2

Protein Chaperone:
YDJ1

ABC Multi-drug Transporter:
SNQ2

Transcriptional Regulator of Stress
Response:
MOT3

Transcription of rDNA:
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RRN10

Ion Transporter/Metal Homeostasis:
PHO84

Miscellaneous Function:
MOG1

Miscellaneous Function:

XYL2

BUD30

VVS1 (YBR241C)

GUA1

TVS1 (YCR061W)

PRM7

YHI9

SAM1

Combined genomic datasets implicate nutrient starvation
The genomic datasets individually revealed pathways involved in MCHM response, such
as ESR activation from the transcriptome and vATPase and mitochondrial mutant sensitivity in
the genetic screen. We decided to compare the genetic screen and transcriptome datasets to
identify shared genes that might be especially important to MCHM response. The upregulated
genes found in the knockout screen included those involved in mitochondrial function and ROS
stress responses (Figure 2D and Table 1). GGC1 and TGL2 encode mitochondrial proteins
involved in GTP/GDP transport and triacylglycerol lipase activity at the mitochondria
respectively (Ham et al., 2010; Vozza et al., 2004). The GGC1 knockout in particular produces
petite yeast which are known to be sensitive to MCHM (Pupo, Ayers, et al., 2019; Vozza et al.,
2004). The POS5 gene, identified originally for conferring peroxide sensitivity, is a mitochondrial
protein that acts as an NADH kinase (Krems et al., 1995; Strand et al., 2003). It is required for
maintenance of mitochondrial DNA, the loss of which results in the aforementioned petite
yeast, as well as detoxification of ROS in the mitochondria (Strand et al., 2003). The presence of
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these genes in both datasets points to the importance of mitochondrial function in the
response to MCHM stress, most likely due to ROS production.
The other major insight of the combined screen and upregulation datasets is the
presence of several amino acid biosynthetic genes. Many of these genes fall under the control
of the general amino acid activator Gcn4 (Braus, 1991). Several single genes from pathways for
isoleucine/valine (ILV6), methionine (MET22), and lysine (LYS2) were found in the overlap.
Furthermore, the aromatic amino acid biosynthetic genes ARO1 and ARO3, as well as four out
of five tryptophan biosynthetic genes (TRP2, TRP3, TRP4, and TRP5), were found in both
datasets. As tryptophan pathways in particular, but also tyrosine, have previously been
implicated in the response to multiple types of stress including nutrient starvation, pH, metal
ions, SDS, and DNA damaging chemicals, the precise role of TRP genes in MCHM tolerance
remains to be elucidated (Godin et al., 2016; González et al., 2008; Schroeder & Ikui, 2019).
The downregulated dataset overlaps with the screen also revealed genes involved in
nutrient homeostasis (Figure 2E). PRS1, PRS3, and TAT1 provide more evidence for the
significance of tryptophan and amino acid metabolism in MCHM sensitivity. PRS1 and PRS3
encode 5-phospho-ribosyl-1(alpha)-pyrophosphate (PRPP) synthetase genes which are
necessary for the production of purines and pyrimidines, and histidine and tryptophan amino
acids (A. T. Carter et al., 1997; Andrew T. Carter et al., 1994; Hernando et al., 1999). While there
are five paralog PRPP synthetases in yeast (Prs1-5), different multimeric complexes of the
paralogous proteins are likely involved in producing wildtype levels of PRPP. Disruptions in PRS1
and PRS3 have the largest reduction in PRPP pools for nucleotide and amino acid production
(Hernando et al., 1999). The protein product of the TAT1 gene is an amino acid transporter,
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characterized originally for its high-affinity import of tyrosine, but also shown to be a lowaffinity transporter of tryptophan (Schmidt et al., 1994). The combined screen and
transcriptomic profiles indicated that MCHM may cause yeast cells to undergo nutrient
starvation, possibly nitrogen specifically, despite growing in rich media. Cells may be
responding by initiating cell cycle arrest and reapportioning nitrogen resources until recovered.
The importance of the aromatic amino acid synthetic genes in MCHM tolerance was
investigated by additional supplementation of tryptophan, tyrosine, and phenylalanine in rich
media containing MCHM. This was insufficient to rescue the growth of either wildtype or
pathway gene knockout strains in MCHM (Figure 3A). It is possible that the excess tryptophan
was not sufficiently imported into the cells based on the sorting of transporters such as Tat2 to
the vacuole instead of the membrane (Schroeder & Ikui, 2019). This is plausible as ergosterol
levels in the cell affect this sorting preference, and MCHM is known to alter sterol levels in the
cell (Pupo, Ku, et al., 2019; Umebayashi & Nakano, 2003). Overexpression of TAT2 using a
multicopy tiling plasmid did not rescue growth on MCHM with or without supplemental
aromatic amino acids (Supplemental Figure 2). The levels of several amino acids increase with
MCHM treatment, including the levels of tyrosine (Pupo, Ku, et al., 2019). Unfortunately, the
levels of tryptophan were not measured by GC-MS, so it is unknown if levels change with
MCHM treatment. Yeast cells seem to be experiencing a nutrient starvation signal upon
exposure, reacting by increasing production of amino acids in a way that is required according
to knockouts from the screen, and yet failing to adapt to the chemical, based on the presence
of excess amino acids alone.
Uncharacterized ORFs both upregulated by and required for MCHM responses.
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Of note in the combined datasets is the requirement of YBR241c for tolerance to
MCHM (Table 1). Ybr241c is a paralog of the vacuolar sorting protein, Vps73, and is localized to
the vacuolar membrane (Matsumoto et al., 2013). Acidification of the vacuole is critical for
metabolizing chemicals such as MCHM and Ybr241c relocalizes to the cytoplasm when
acidification of the vacuole is blocked (Matsumoto et al., 2013). Ybr241c also physically
interacts with Gtt1, a glutathione transferase of vacuolar proteins (Chandel et al., 2016; Yu et
al., 2008). Like Vps73, Ybr241c shares homology with other sugar transporters such as Hxt1-17
and related proteins. As Ybr241 is a vacuolar protein vital for stress response, we named it
Vvs1. Ycr061w localizes to cytoplasmic puncta that do not appear to be vacuoles but instead
vesicles (Huh et al., 2003; Tkach et al., 2012). Ycr061w contains 10-11 predicted
transmembrane domains (Weill et al., 2019). As Ycr061w is a transmembrane protein vital for
stress response, we named it Tvs1.
Growth rescue by glutathione.
As mitochondrial processes and iron ion homeostasis were found to be significant
results in the genomic datasets, we further explored the role of reactive oxygen species in
MCHM-induced stress. Glutathione serves as an antioxidant for the cell, particularly in the
mitochondria and ER, and is also important in iron-sulfur homeostasis (Bulteau et al., 2012). It
was hypothesized that treatment with glutathione may rescue ROS stress created by exposure
to MCHM, so yeast were co-treated with the chemicals. Glutathione was sufficient to rescue
the growth of wildtype yeast, even at extremely high doses of 600ppm (Figure 3B). Tryptophan
levels are important for resistance to DNA damaging agents (Godin et al., 2016). However,
glutathione was not able to rescue the sensitivity of the aro1 mutant, so the unknown non41

amino acid role in MCHM tolerance of the aromatic amino acid biosynthetic genes does not
seem to be related to an ROS stress mechanism. The sensitivity of the aro1 knockout mutant
was replicated in a divergent yeast strain background, YJM789 (Figure 3B), to control for
genetic background specific sensitivity.
The yeast vacuolar ATPase was the second most significant GO term from the genetic
screen dataset. The v-ATPase is responsible for acidifying the vacuole of yeast cells by
hydrolyzing ATP in order to pump hydrogen ions into the vacuole, creating an electrochemical
gradient with multiple homeostatic roles (Deranieh et al., 2015; H. Nelson & Nelson, 1990; N.
Nelson & Harvey, 1999; Nishi & Forgac, 2002; Ohya et al., 1991). vma mutants show at least
three sensitivity phenotypes that may be related to MCHM’s effects, including metal ion
homeostasis, pH sensitivity, and oxidative stress sensitivity. To test if oxidative stress may be
responsible for the sensitivity of vma mutants, we co-treated these mutants with MCHM and
glutathione (Figure 3C). The observed growth rescue with glutathione treatment supports the
hypothesis that the v-ATPase is required to provide a robust level of ROS protection yeast cells
need to survive MCHM.
The antioxidant glutathione is a tripeptide of glycine, glutamate, and cysteine, and
therefore, it is also potentially a source of nitrogen for cells. This complicates the interpretation
of its role as an antioxidant source in rescue assays, given the role of nutrient deprivation upon
exposure to MCHM. We tested if glutathione was acting solely as an antioxidant by treating the
glr1 knockout mutant with MCHM and oxidized glutathione. Glr1 is the glutathione reductase
required to convert oxidized glutathione to reduced glutathione that can act as an antioxidant
(Couto et al., 2016). The oxidized glutathione was able to rescue the wildtype BY4742 strain and
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glr1 mutant as well as reduced glutathione (Supplemental Figure 3). As the glr1 mutant was
rescued, the role of glutathione as antioxidant is called into question. We also treated cells with
ammonium sulfate to test rescue by a general nitrogen source supplement, but the
combination with MCHM was surprisingly toxic to cells (Supplemental Figure 3). As
supplementation by aromatic amino acids, another nitrogen source, also failed to rescue
growth, it is clear that if glutathione is acting as a nitrogen source instead of an antioxidant, it is
unique among nitrogen supplements in its ability to alleviate the MCHM growth defect in cells.
Biochemical assays for the presence of ROS in MCHM treated cells.
As genomic datasets and mutant growth assays had implicated ROS production as an
effect of MCHM treatment, we attempted to directly detect ROS inside the cell. The dye
dihydroethidium (DHE) reacts with intracellular ROS and then creates a fluorescent signal. We
dyed yeast treated with MCHM with DHE, then detected the changes in fluorescent signal in
the populations via flow cytometry. The flow cytometry results revealed an increase in
fluorescence for a subpopulation of wildtype cells (Figure 4A). Within the genetic clonal
population of MCHM treated cells represented by the red curve, phenotypic heterogeneity
existed. The majority of MCHM treated cells did not have an increase in ROS levels, in contrast
to hydrogen peroxide treated yeast (gray line). However, a subpopulation of the red curve, as
seen in the portion of the curve under the marker labeled High ROS, did have increased ROS.
The High ROS subpopulation of cells increased from 2.96% to 7.82% of the total cellular
population in the BY4741 strain (Supplemental Figure 4). It is a known phenomenon that clonal
populations in liquid culture can show phenotypic heterogeneity, specifically with respect to
ROS sensitivity (Sumner et al., 2003). This may explain why there is little reduction in the
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viability of BY4741 cells seen in Figure 1B. If the cells that successfully arrest their cell cycle
were able to adapt and minimize their ROS production to avoid MCHM-induced death, they
may appear as the large subpopulation with a lower ROS signal in the data. The cells that failed
to do so may represent both the few cells that die in the viability assay, as well as those
appearing as the small peak in the High ROS range. This assay revealed the first direct evidence
that MCHM treatment produces ROS in the cell, in agreement with the indirect evidence
originally seen in the sensitivity of vma mutants, glutathione rescue, and previous studies
involving petite yeast (Pupo, Ayers, et al., 2019).
While the effects of MCHM on yeast point to an increase in ROS stress for the cell,
wildtype cells seem to be robust enough, on average, to limit this stress, while mutants in
certain pathways cannot. To test this hypothesis, we also performed the DHE assay on one of
the most sensitive knockout mutant strains, vma3, which previously showed rescued growth
with glutathione treatment. This mutant strain showed a similar pattern of DHE fluorescence
when treated with MCHM, with the appearance of a High ROS population peak (Figure 4B). The
major difference from the wildtype was an increase in the size of the High ROS population peak.
The High ROS population in the vma3 strain rose from 1.08% to 22.19% of all cells
(Supplemental Figure 4). The mutant strain also appeared to show a right-shift of the
background ROS populations as well. This may indicate vma mutants have higher ROS levels in
unstressed conditions. Therefore, these strains have an innate sensitivity to MCHM due to their
inability to maintain ROS homeostasis. We hypothesize that robust cells were able to detect the
increased ROS caused by MCHM stress, then adapt to this by arresting growth and limiting their
background ROS production.
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MCHM treatment causes DNA damage to wildtype yeast cells.
We also questioned whether the ROS produced in MCHM treated cells may cause DNA
damage, a known complication in ROS stressed cells (reviewed in Ayer et al., 2014; Brennan et
al., 1994; Lafleur & Retèl, 1993; Perrone et al., 2008; Temple et al., 2005). To address this
question, a comet assay was performed to directly measure damage. This assay uses
microscopy to measure the length of “tails”, resembling comets, released from spheroplasted
and lysed cells, and migrated across agarose covered slides via electrophoresis (Figure 4C-F).
Longer tails indicate DNA fragments, presumably from damage resulting in double-stranded
breaks. Yeast cells treated with MCHM concentrations of 550 ppm showed significantly longer
comet tails as compared to no treatment and no spheroplast controls (Tukey’s test p adj =
0.0437 and 0.000229 respectively) and approached significance as compared to 5mM H 2O2
positive controls (p adj = 0.0655). This is the first direct evidence of DNA damage from MCHM
treatment, confirming implications of data such as the ROS assay, cell cycle arrest, and other
stress response data in previous studies (Lan et al., 2015).
Discussion:
The evidence presented here supports a model where MCHM activates the general
environmental stress response programming of the yeast cell via Msn2/4 transcription factors,
including specific responses consistent with ROS stress and nutrient starvation. Cell cycle arrest
begins within 30 minutes of treatment, likely due to the initial signaling of nutrient starvation.
These signals inactivate growth mechanisms soon after the cell is exposed, but before ROS
accumulate. The ROS stress accumulates over six to twelve hours and the asynchronous
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population of cells continues to arrest in G1 during this time period. The long duration of the G1
arrest in MCHM treated cells is similar to that seen in nutrient starvation (Gasch et al., 2000;
Gasch & Werner-Washburne, 2002). It is in contrast to other stresses such as oxidative stress
and heat shock, which are more transient, with growth resuming after a short acclimation
period to the stress. After a long acclimation period, robust strains such as wildtype were able
to manage the stress, recover, and return to proliferation (Figure 5) at dosage levels
significantly higher than those found in the Elk River spill. In this model, several signals initiate
multiple stress responses, including nutrient starvation, reactive oxygen species, and DNA
damage itself, but the nutrient starvation accounts for the most likely primary stress controlling
the ESR and G1 arrest.
Nonetheless, there is direct evidence of ROS production and DNA damage, as well as
rescue by treatment with glutathione which may be acting as either an antioxidant or a
nitrogen source. Other data have previously indicated that petite yeast, known to be sensitive
to ROS, are also sensitive to MCHM, and this agrees with the sensitivity of the mitochondrial
translation mutants revealed in the genetic screen data of this study (Pupo, Ayers, et al., 2019).
The vacuolar ATPase mutants, which are sensitive to metal and pH stress, as well as ROS, were
one of the other most enriched GO terms from the screen. This study, combined with previous
data, points to MCHM as a source of perturbation for metal ions and ROS (Lan et al., 2015;
Pupo, Ayers, et al., 2019).
The list of overlapping genes from the screen and the upregulated datasets included
SNQ2, an ABC multidrug transporter associated with the removal of foreign substances from
the cell (Figure 2D) (Decottignies et al., 1995; Decottignies & Goffeau, 1997; Rogers et al., 2001;
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Servos et al., 1993). While there are several such transporters (and related transcription
factors) found in the transcriptomics, this is the only one found in the screen to be required for
the tolerance of MCHM. We hypothesize that this transporter is responsible for the removal of
MCHM or a related toxic byproduct from the cell. Future work on MCHM tolerance should
include exploration of the relative roles of different ABC transporters in export of the chemical.
Another possible avenue for study is control of Gcn4 and its related genes in the
nutrient starvation signal detected during MCHM exposure. As previously noted, the amino acid
biosynthetic genes ILV6, MET22, LYS2, ARO1, ARO3, TRP2, TRP3, TRP4, and TRP5 are all under
Gcn4 control and are required for and upregulated in MCHM tolerance (Figure 2D and Table 1).
The screen overlap with the downregulated dataset also includes several Gcn4-related genes
(Figure 2E and Table 1). BUD27 is related to translation initiation and may be involved in the
expression of genes controlled by Gcn4 (Deplazes et al., 2009; Gstaiger et al., 2003; MirónGarcía et al., 2013). GUA1 is negatively regulated by nutrient starvation and its mutants have
been shown to be impaired in GCN4 translation (Escobar-Henriques et al., 2003; EscobarHenriques & Daignan-Fornier, 2001; Iglesias-Gato et al., 2011). PRM7 also contains Gcn4
binding elements, connecting it to control by this transcriptional activator (Schuldiner et al.,
1998). GCN4 was not upregulated upon MCHM treatment at the transcriptional level. However,
it is also controlled translationally, so it could have been upregulated at the protein level
(Hinnebusch, 1997; Meimoun et al., 2000). It was also not required for tolerance in the genetic
screen despite the importance the amino acid biosynthetic genes. Exploration of the
background levels of expression of these genes in the gcn4 knockout mutant could reveal if that
is sufficient to perform their required functions in MCHM resistance.
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Evidence of nutrient starvation is supported by the overlapping genomic datasets, as
well as previous work which revealed that several amino acid levels increase in the cell (Pupo,
Ku, et al., 2019). Glutathione, in both its reduced and oxidized forms, were able to rescue
growth, indicating that it may be acting as a nitrogen source instead of an antioxidant.
However, treatment with excess aromatic amino acids nor general nitrogen sources such as
ammonium sulfate could rescue growth. The cell’s programmed response to nutrient starvation
is initiated by the cell to respond to MCHM, as wildtype cells upregulate the cellular and
aromatic amino acid biosynthetic pathways. Furthermore, mutants lacking genes in these
pathways, those in aromatic amino acids and tryptophan, in particular, are more susceptible to
MCHM than wildtype cells, even in rich media with excess aromatic amino acids available.
The major question remains why the aromatic amino acid biosynthesis genes, including
all but one of the tryptophan pathway genes, are required for resistance to the chemical.
Supplementation with excess tryptophan in YPD did not rescue growth on MCHM, but it is not
clear if this supplementation increased intracellular levels of tryptophan. It is possible the
sorting of the transporter Tat2 to the plasma membrane was insufficient to import excess
tryptophan. Furthermore, GC-MS failed to measure intracellular levels of tryptophan. While
overexpression of TAT2 was previously sufficient to rescue SDS sensitivity in mck1 knockout
mutant cells(Schroeder & Ikui, 2019), a multicopy plasmid expressing the TAT2 region of
chromosome XV was not able to rescue growth on MCHM. Another hypothesis is that the
biosynthetic genes themselves are important for signaling recovery from stress so that cells
may resume proliferation, regardless of the actual levels of aromatic amino acid products
related to the pathway. The trp1-5 mutants are sensitive to rapamycin (González et al., 2008),
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so it is possibly a recovery phenotype. The chemical glutathione can rescue MCHM treatment in
wildtype cells, but it cannot do so in these mutants. Whether glutathione is ameliorating ROS
stress or providing a specific nitrogen supplement when it rescues wildtype cells, it cannot do
the same for these mutants. They may be required to perform a signaling role in the recovery
after stress acclimation. Another possibility is that there is a separate source of stress besides
nutrient availability or ROS that the genes are required to address, such as production or
conversion of other small molecules. It would be useful to determine if there are other
stressors for which these genes are required, regardless of amino acid levels, to address the
possibility that this is specific to MCHM exposure.
The Elk River MCHM spill revealed that there are many things we do not know about the
industrial chemicals that we live among. This and other studies since have revealed that levels
of the chemical may not be acutely toxic, but there are immense and still only partially
characterized effects on the biochemical pathways that control eukaryotic metabolism. This
chemical causes the production of reactive oxygen species and DNA damage in yeast and alters
the transcriptome and metabolome in extensive ways. While the effects on possible nutrient
starvation and associated amino acid biosynthesis are not fully understood, cells with robust
homeostatic processes are generally able to activate the environmental stress responses
programmed in their genes to recover from MCHM exposure and resume proliferation.
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Figures:

Figure 1: Growth and viability of yeast under MCHM treatment. A. Growth of 10-fold dilutions
of yeast on YPD media with and without MCHM treatment. BY4741 strain is derived from the
S288c background. B. Acute viability assay of the MCHM sensitive strain BY4741 treated with
MCHM for 1.5 hours and 24 hours. Colony-forming units for three biological replicates were
averaged for each treatment then normalized to media without MCHM treatment. In YPD yeast
were exposed to 400ppm and 550ppm crude MCHM. C. Proportion of log-phase BY4741 in G1,
S, or G2/M phases of the cell cycle based on flow cytometric analysis grown in YPD. D.
Histograms of DNA content in BY4741 population grown in YPD shown in part C, as based on
fluorescence intensity of sytox green. E. The proportion of log-phase BY4741 in G1, S, or G2/M
phases of the cell cycle based on flow cytometric analysis grown in YPD with 550ppm MCHM. F.
Histograms of DNA content of BY4741 population grown in YPD treated with MCHM shown in
part E, as based on fluorescence intensity of sytox green. All samples were analyzed for 0, 0.5,
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1.5, 6, and 12-hour time points to monitor cell cycle changes over time. (All parts were
performed by Michael C. Ayers)
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Figure 2: Genetic screen of knockout collection and RNAseq of BY4741 gene lists. A. Select top
biological process GO Terms for the list of 329 genes found to be hits in the genetic screen of
BY4742 knockout collection. Benjamini-Hochberg adjusted p-values reported by DAVID
software are shown for each term. B. Select top biological process GO Terms for the 592
significantly upregulated genes from BY4741 treated with MCHM versus untreated YPD. FDR is
shown for each term. C. Select top biological process GO Terms for the 572 significantly
downregulated genes from BY4741 treated with MCHM versus untreated YPD. FDR is shown for
each term. D. Venn diagram of the overlap between the 329 genes from the genetic screen and
the upregulated genes. E. Venn diagram of the overlap between the 329 genes from the genetic
screen and the downregulated genes. (Michael Ayers performed the knockout screen and
analysis in part A and all downstream analysis of transcriptome and knockout GO term and
intersection analyses in parts B through E. Jennifer Gallagher performed RNA experiment and
Amaury Pupo performed differential analysis for transcriptome in Parts B through E. from
previous study Gallagher et al., 2020.)
69

Figure 3: Sensitive mutants from gene lists cotreated with possible rescuing chemicals A. 10fold serial dilution growth assay of knockouts of aromatic amino acid biosynthesis genes found
in the genetic screen. Strains were cotreated with MCHM and aromatic amino acids Tryptophan
(W), Tyrosine (Y), and Phenylalanine (F) in rich media, testing the extra supplementation of
these amino acids beyond normal levels in YPD. B. 10-fold serial dilution growth assay of
wildtype strains and knockout of aromatic amino acid biosynthetic gene ARO1 with and without
cotreatment of 10mM antioxidant glutathione (GSH) and MCHM. C. 10-fold serial dilution
growth assay of knockouts in the vacuolar acidification pathway as found in the genetic screen.
Strains were cotreated with and without 10mM antioxidant GSH and MCHM. (All experiments
and analysis were performed by Michael C. Ayers)
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Figure 4: Flow cytometry and comet assay of yeast strains reveals the production of Reactive
Oxygen Species and DNA damage. Levels of ROS in strains of yeast exposed to MCHM, based
on fluorescence of the ROS-reactive dye DHE. Yeast were incubated for 12 hours with or
without MCHM then stained with DHE for 20 minutes before cells were sorted using flow
cytometry. Hydrogen peroxide treatment for 1.5 hours was used as a positive control to
generate ROS in control cells (grey line). Background ROS of untreated yeast in blue measures
endogenous ROS compared to unstained yeast with no DHE (black). MCHM treated yeast are in
green while MCHM treated yeast stained with DHE are in red. Markers were inserted on the
histogram to indicate a range of fluorescence corresponding to background or high ROS based
on peaks for untreated control cells. Histograms are for the strains A. BY4741, and B. vma3
knockout mutant. C-F. Examples of cells visualized by microscopy for the comet assay. Cells
underwent treatment prior to spheroplasting, electrophoresis on a slide, and visualization via
microscopy and ethidium bromide staining. Lengths of tails were measured with TriTek
CometScore 2.0.0.38 software. The samples shown are examples of the following treatments C.
5mM H2O2, D. 10mM H2O2, E. 550ppm MCHM, and F. 1000ppm MCHM. G. Graph of tail lengths
of cells determined via comet assay. (Michael C. Ayers performed the flow cytometry and
follow-up analyses in parts A and B. Zachary Sherman performed the comet assay and analysis
in parts C-G.)
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Figure 5: Model of response and tolerance of yeast cells to MCHM treatment. Diagram of
yeast cell showing MCHM entering cell and causing ROS, DNA damage, and possible nutrient
starvation. These signals are shown triggering environmental stress response leading to cellular
responses that lead to recovery and resumption of replication. (Model was made by Michael C.
Ayers)
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Supplemental Figure 1: Diagram of the genetic screen of haploid BY4742 knockout collection.
The 96-well plates of the knockout collection were each inoculated into growth chambers in
triplicate by pinning and grown for two days to saturation. These chambers were then serially
diluted 20-fold three times into new 96 well plates, before being pinned onto YPD agar plates
with or without 300ppm MCHM. Pictures were taken after 3 days of growth and scored for
growth defects consisting of decreased growth of at least a full spot on MCHM plates compared
to control strain (wt BY4742) and control plate growth. (Genetic screen was designed by
Michael C. Ayers)
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Supplemental Figure 2: TAT2 overexpression does not rescue the MCHM growth defect. 10fold serial dilution growth assay of BY4742 with indicated plasmids on minimal and rich media
with indicated treatment with MCHM and supplemental aromatic amino acids tryptophan (W),
tyrosine (Y), and phenylalanine (F). pRS315 is a control CEN plasmid expressing the LEU2 marker
to confer growth on leu- media to the wild-type BY4742 without overexpression of any genomic
regions. TAT2 overex. contains a tiling array multicopy plasmid with the genomic region of
chromosome XV containing TAT2 for its overexpression (from the IFM1 ORF to the left of TAT2
to the YOL019W-A ORF to the right, six complete ORFs and one partial). The control region right
plasmid is the same multicopy tiling array plasmid but with the genomic region flanking the
TAT2 ORF on the right side, from within the TAT2 ORF to the YOL015W ORF (six complete ORFs
and two partials). The control region left plasmid is the same multicopy tiling array plasmid but
with the genomic region flanking the TAT2 ORF on the left side, from the IFM1 ORF to the DIS3
ORF directly to the left of TAT2 (two complete ORFs and two partials). (All experiments were
performed by Michael C. Ayers)
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Supplemental Figure 3: glr1 mutant rescued by oxidized glutathione, but not general nitrogen
supplement. 10-fold serial dilution growth assay of BY4742 and knockout mutants for glr1,
aro1, trp5, and vma3. The mutants were grown on rich media containing 0ppm, 400ppm or
550ppm MCHM, as well as cotreatments with 10mM reduced glutathione (GSH), 5mM oxidized
glutathione (GSSG), or 10mM ammonium sulfate ((NH4)2SO4). (Michael C. Ayers performed this
experiment)
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Supplemental Figure 4: Increased percentage of High ROS cells with MCHM treatment.
Percentages of High ROS subpopulation of cells from the BY4741 wiildtype and vma3 mutant
strains, based on fluorescence of the ROS-reactive dye DHE are shown. Yeast were incubated
for 12 hours with or without MCHM then stained with DHE for 20 minutes before cells were
sorted using flow cytometry. Fluorescence level (350) for determining High ROS subpopulation
was based on approximately 95% (94.69%-96.86%) of H2O2 positive control cells in all three
BY4741 replicates being above this fluorescence level. Bar graph shows the averages of three
biological replicates for each strain and treatment with standard error bars. One-tailed t-test
was used to determine p-values. (The flow cytometry and this analysis were performed by
Michael C. Ayers)
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All Supplemental Tables and Files are available at https://github.com/wvumayers/MCHMGenetic-Screen.
Table S1: Full list of knockout strains found as hits in the genetic screen of the BY4742
collection. Includes ORF and gene names of all 329 hits from the screen. 4983 strains from the
haploid knockout collection were assayed for growth in the presence of 300ppm MCHM on
solid YPD media. While approximately 900 strains showed some noticeable growth differences
on at least one replicate, the 329 strains showed clear growth differences on all 3 biological
replicates, accounting for a stringent threshold for inclusion as a “hit” for the knocked out gene
being required for MCHM resistance.
Table S2: Full results of significantly upregulated genes from RNAseq data in MCHM/YPD
using BY4741 wildtype strain. Upregulated transcripts from the BY4741 RNAseq are listed in
full. Included are the ORF names, as well as log2fold change and adjusted p-values supplied by
the differential analysis. All genes are at least greater than a two-fold increase in expression in
MCHM than YPD. Gene names, locations, and putative functions are concatenated to the
rightmost columns of the table for further information on included ORFs.
Table S3: Full results of significantly downregulated genes from RNAseq data in MCHM/YPD
using BY4741 wildtype strain. Downregulated transcripts from the BY4741 RNAseq are listed in
full. Included are the ORF names, as well as log2fold change and adjusted p-values supplied by
the differential analysis. All genes are at least greater than 2fold decreased in expression in
MCHM than YPD. Gene names, locations, and putative functions are concatenated to the
rightmost columns of the table for further information on included ORFs.
Supplemental File 1: Full GO terms for the genetic screen of BY4742 knockout collection. Excel
file containing 3 tabs. Tab 1 gives DAVID GO term results for the biological process. Tab 2 gives
DAVID GO term results for molecular function. Tab 3 gives DAVID GO term results for the
cellular component.
Supplemental File 2: Full GO terms for significantly upregulated genes of BY4741 yeast
treated with MCHM. Excel file containing 3 tabs. Tab 1 gives DAVID GO term results for the
biological process. Tab 2 gives DAVID GO term results for molecular function. Tab 3 gives DAVID
GO term results for the cellular component.
Supplemental File 3: Full GO terms for significantly downregulated genes of BY4741 yeast
treated with MCHM. Excel file containing 3 tabs. Tab 1 gives DAVID GO term results for the
biological process. Tab 2 gives DAVID GO term results for molecular function. Tab 3 gives DAVID
GO term results for cellular component.
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CHAPTER 4: MCHM ACTS AS A HYDROTROPE, ALTERING THE BALANCE OF METALS IN YEAST
A paper published in the journal Biological Trace Element Research
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Abstract
While drugs and other industrial chemicals are routinely studied to assess risks, many widelyused chemicals have not been thoroughly evaluated. One such chemical, 4-methylcyclohexane
methanol (MCHM), is an industrial coal-cleaning chemical that contaminated the drinking-water
supply in Charleston, WV, USA in 2014. While a wide range of ailments was reported following
the spill, little is known about the molecular effects of MCHM exposure. We used the yeast
model to explore the impacts of MCHM on cellular function. Exposure to MCHM dramatically
altered the yeast transcriptome and the balance of metals in yeast. Underlying genetic variation
in the response to MCHM and transcriptomics and mutant analysis uncovered the role of the
metal transporters, Arn2 and Yke4, to MCHM response. Expression of Arn2, involved in iron
uptake, was lower in MCHM-tolerant yeast and loss of Arn2 further increased MCHM tolerance.
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Genetic variation within Yke4, an ER zinc transporter, also mediated response to MCHM and
loss of Yke4 decreased MCHM tolerance. The addition of zinc to MCHM-sensitive yeast rescued
growth inhibition. In vitro assays demonstrated that MCHM acted as a hydrotrope and
prevented protein-interactions, while zinc induced the aggregation of proteins. We
hypothesized that MCHM altered the structures of extracellular domains of proteins, and the
addition of zinc stabilized the structure to maintain metal homeostasis in yeast exposed to
MCHM.

Background
The potential for significant human exposure to toxic substances is increasing as thousands of
chemicals in routine use have had little safety testing [1–3]. 4-Methylcyclohexanemethanol
(MCHM) is an alicyclic primary alcohol used as a cleaning agent in the coal industry. Although
health and safety information for this compound is limited, its widespread use in the coalproducing regions of the United States represents a potential hazard to humans and
ecosystems. In January 2014, a large quantity of MCHM was spilled into the Elk River in West
Virginia, USA and contaminated the drinking water supply of 300,000 people, exposing them to
unknown health risks [4]. People exposed to MCHM through the contaminated drinking water
reported a variety of significant ill effects [5].
MCHM is not easily degraded biologically because of its low reactivity [6]. In contrast to other
well-studied hydrocarbons, such as cyclohexane and benzene, the effects of MCHM on
metabolism are under studied [7]. Yeast lines exposed to MCHM exhibited increased expression
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of proteins associated with the membrane, cell wall, and cell structure functions, while MCHM
metabolites mainly induced proteins related to antioxidant activity and oxidoreductase activity
[3]. With human A549 cells, MCHM mainly induced DNA damage-related biomarkers, which
indicates that MCHM is related to genotoxicity due to its DNA damage effect on human cells
[3].

Yeast provide an ideal model system to understand the interplay between metabolic pathways
involved in the transport, toxicity, and detoxification of MCHM. Further, the use of yeast strains
with mutations in various metabolic pathways allows direct evaluation of targeted pathways on
the fate and toxicity of MCHM in cells. “Petite yeast”, lines with mutations that disrupt the
electron transport chain that produces ATP in the mitochondria, grow more slowly and have
smaller cell size than “grande yeast” (wild type). Because these yeast mutants can generate
sufficient energy through glycolysis, however, these are not lethal mutations, but provide a
slow-growing line to evaluate the metabolic rate and stress response. In addition to their roles
in energy transformations, mitochondria are central for the synthesis of amino acids,
nucleotides, and heme and Fe-S cluster proteins. Thus, such yeast lines are ideal models to
assess the role of mitochondrial function in response to stress.

Petite yeast have different tolerances to chemicals, which may be related to the production of
reactive oxygen species (ROS) and mitochondrial function. For example, petite yeast are more
tolerant to 4-nitroquinoline 1-oxide (4NQO) than grande yeast when grown on non80

fermentative carbon sources that favor respiration [8, 9]. 4NQO is metabolized to the active
form only in cells with functional mitochondria, and petite yeast, without mitochondria and
favoring fermentation, are more resistant than wild type yeast. However, petite yeast have
higher levels of endogenous ROS and are sensitive to compounds that also generate ROS [10],
such as MCHM. Petite yeast are additionally more sensitive to H2O2 [10, 11] but more resistant
to copper [12]. Sod1 is the main dismutase that neutralizes ROS in the cytoplasm, and in the
mitochondria, Sod2 also neutralizes ROS. Thus, the petite yeast-grande yeast pair represent an
ideal system to evaluate the role of ROS systems, metal homeostasis, and MCHM toxicity.

The hydrophobicity of MCHM alters membrane dynamics, which changes how cells can respond
to the environment, including the import and subcellular localization of metals. Metal
homeostasis is critical in that metals, such as iron (Fe) and zinc (Zn), play important roles in
metabolism as co-factors for enzymes and other proteins, yet, if in excess, induce broad lesions
to cell biology through the generation of ROS and by binding to a variety of biomolecules [13].
The coordinated activity of metal uptake and sequestration transporters function to maintain
metals at optimal levels (Figure 1). For example, there are two Zn transporters located on the
cell membrane of yeast. Zrt1 is the high-affinity transporter that transports Zn when
extracellular levels are low [14], and Zrt2 is the low-affinity transporter [15]. Zrt3 transports Zn
from storage in the vacuole to the cytoplasm when needed [16], while Zrc1, the Zn/H+
antiporter, and its paralog Cot1 [16, 17] transport Zn into the vacuole from the cytoplasm. Izh1
and its paralog Izh4 are both involved in Zn homeostasis by altering membrane sterol content
or by directly altering cellular Zn levels [18, 19].
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In the current study, we evaluated the impacts of MCHM on petite and grande yeast strains,
focusing on metal ion homeostasis and divergent respiratory pathways in these lines as
potential mechanisms of MCHM sensitivity. We integrate transcriptomics, ionomics, and QTL to
identify Fe and Zn homeostasis as central to MCHM toxicity, and suggest that loss of metal
homeostasis underlies ROS damage and MCHM toxicity. While the MCHM has low solubility in
aqueous solutions, we propose that MCHM acts as a hydrotrope, altering membrane dynamics
and changing how cells responded to nutrients, including import and subcellular localization of
metals via transmembrane ion transporters.

Experimental Procedures
Yeast strains and media
S96 petite yeast were previously generated from S96 (MATa lys5) with a six hour incubation
with ethidium bromide. The petite phenotype was validated by failure to grow on glycerol and
loss of COX2 from the mitochondrial genome [9]. Yeast knockout strains were previously
generated in the BY4741 background [20]. The entire coding regions of YKE4 were knocked out
with hygromycin resistance marker in S96 and YJM789 [21]. S96-derived strains were grown in
minimal media supplemented with lysine, while BY4741 strains grown in minimal media were
supplemented with histidine, methionine, uracil, and leucine. S96 and BY4741 are considered in
the S288c genetic background while YJM789 is a clinical isolate [22]. Crude MCHM provided
directly from Eastman Chemical.
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QTL analysis
Isolates of the recombinant haploid collection between S96 and YJM789 [23] were utilized to
perform a QTL analysis for MCHM tolerance. A genetic map was constructed and combined
with phenotypes collected by growth curves of the segregants in YPD containing MCHM using a
TECAN M200 plate reader. Briefly, cultures of segregants were grown overnight then diluted to
0.1 OD600 starting concentrations in 200 µl of YPD and either 0 ppm (0 mM) control or 400 ppm
(2.8 mM) MCHM. Each segregant was grown in biological triplicate for both control and MCHM
treatments in 96-well plates. Both parent strains were grown on every plate to normalize plateto-plate variation. Plates were grown with constant shaking and OD data was collected every 10
minutes for 24 hours. Differences in control and MCHM saturated concentrations from hours
14-19 of the growth curves were averaged into a single data point to serve as the phenotype
for each segregant.
The S96  YJM789 segregant collection used for genetic analysis contains 126 segregants
genotyped at 55,958 SNPs identified by physical location. To perform the QTL analysis as
previously described [24, 25], the genetic map was estimated for use in place of the existing
physical map. Computational efficiency was also improved by collapsing the 55,958 markers
into only 5,076 markers. The R/QTL package based this reduction of markers on by finding
regions of markers that did not recombine and segregate amongst the offspring, which it
collapsed into individual randomly selected markers within the linked region. The genetic map
was created using R version 3.4.3 and the QTL package version 1.41.6. The scripts contained in
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Karl W. Broman’s genetic map construction guide were modified for the haploid yeast genome
and used to output the map. The known order and location of markers on the physical map
were used to validate that the genetic map output was ordered correctly. The physical map was
also used to identify linkage names as established yeast chromosomes I to XVI. The QTL analysis
was performed using the maximum likelihood EM algorithm method to calculate LOD scores at
all loci. Significance thresholds of alpha = 0.05 were applied using 1000 permutations to
determine the significance of LOD scores.

Serial dilution assays
Yeast were serially diluted onto solid media as previously described [24]. MCHM and ZnSO4
were added to media, autoclaved and cooled to 65oC, which was then poured. Specific
experimental conditions varying the concentrations of MCHM, zinc, and yeast strains are
outlined in the results.

Transcriptomics
The RNA-seq of S96 and S96 petite yeast was carried out on hot phenol extracted RNA [9]. The
raw reads from sequencing are from 16 samples GSM2915204 through GSM2915219, including
normal and petite cells. "GSE108873_mchm_fC1_count_table_clean.txt.gz" is the count data
generated via Rsubread. "GSE108873_mchm_fC1_DESeq_c2.tsv.gz" is the differential
expression data generated via DESeq2. The accession number is GSE108873
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(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108873). GO term analysis was
undertaken with clusterProfiler [26], an R package that implements methods to analyze and
visualize functional profiles (GO and KEGG) of gene and gene clusters. For this, the ORF names
from genes up- or downregulated in each condition were translated to the corresponding
Entrez id using the function bitr and the package org.Sc.sgd.db. The resulting gene clusters were
processed with the compareCluster function, in mode enrichGO, using org.Sc.sgd.db as
database, with Biological Process ontology, cutoffs of p-value = 0.01 and q value = 0.05,
adjusted by “BH” [27], to generate the corresponding GO profiles, which were then simplified
with the function simplify. The simplified profiles were represented as dotplots, providing up to
15 most relevant categories.

Elemental analysis
Yeast were grown to mid-log phase in YPD at which time MCHM was added to a final
concentration of 550 ppm (3.9 mM). 1.2x108 yeast cells were harvested following 0, 10, 30, and
90 min exposure to MCHM. Samples were split and washed, one set twice with water and the
other washed once with 10 mM EDTA to remove metals adsorbed to the extracellular matrix.
Four biological replicates for each sample were frozen in liquid nitrogen and stored at –80˚C.
Cell pellets were digested in 300 µl of 30% H2O2 and followed by 700 µl of concentrated nitric
acid. Samples were heated to 85˚C until clear. Sample volume was brought up to 10 ml with
HPLC grade water. Digested samples were analyzed in technical triplicate by inductively coupled
plasma emission spectrometry (Agilent 5110 ICP, Agilent, Santa Clara, CA, USA) at the following
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wavelengths for each metal: Ca 393.366, Fe 238.204, Mg 279.553, Na 589.592, P 213.618, and
Zn 206.200. Concentrations of elements in digests (mg l-1) were normalized to protein levels as
determined by Bradford assay.

Hydrotrope assay
Hydrotrope assays were carried out as previously described [28], with the following
modifications. Eggs were purchased and used within one day. Egg whites were separated and
diluted 1:6 in 50 mM Tris-HCl pH 7.4. In glass tubes, 3 ml of diluted egg whites were mixed with
different concentrations of ATP, MCHM, and zinc sulfate. Samples in the glass tubes were read
at 450 nm after 45-60 seconds of incubation at 60˚C water bath. All treatments were done in 34 replicates and averaged together with the standard deviation shown. Statistical differences
were determined using a student t-test.

Spheroplasting
Spheroplasts of the BY4741 yeast strain were prepared as described [29] with the
following modifications. HEPES was used as the buffer and 100 mg 20T zymolase was added per
OD unit (OD600 multiplied by the volume of culture); spheroplasts were incubated for 1 hour at
30˚C. In a 96-well plate, 5 replicates of each treatment were recorded: empty well, spheroplast
media only, no treatment, 0.1% SDS, 0.5% sterile distilled water, 10 mM sorbitol, 1 mM ATP, 10
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mM NaXS, 10 µM ZnSO4, 550-1000 ppm (3.9 to 7.1 mM) MCHM. Using a spectrophotometer,
the absorbance at 600 nm was recorded every 15 hours at room temperature.

Microscopy
Yeast with proteins tagged at the N-terminus with mCherry under the TEF2 promoter [30] were
grown to log phase and then split into 8 different cultures (4 for treated and 4 for untreated).
Once in log-phase, samples were treated with 550 ppm (3.6 mM) MCHM for 30 minutes
followed by a 20-minute incubation time of 25 µM calcofluor white (Biotium catalog number
29067) on a shaker in a dark room. Then 30 µl of each sample onto a microscope slide
pretreated with 40 µL of 250 µg/ ml concanavalin A via pipette onto microscope slides and let
sit under a hood for 30 min to dry. The coverslip was placed on top and nail polish was applied
around the edges to hold coverslip in place. Cells were imaged on Nikon A1R confocal
microscope using a FITC Laser and DAPI laser. Quantitative analysis of pixel intensity to measure
the change in expression of the proteins of interest after exposure to MCHM was done with
ImageJ on 17-20 cells for each condition. The signal was normalized to untreated yeast and
statistical differences were determined using a student t-test.

Results
Petite yeast have different responses to chemicals because the metabolism of the yeast is
shifted away from respiration. Indeed, compared to wild-type (grande) yeast, petite yeast were
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more sensitive to MCHM (Figure 2). Growth inhibition of petite yeast was affected at 125 ppm
MCHM while the growth of wild-type yeast was only affected at 500 ppm MCHM. Yeast have
higher tolerances to MCHM when grown in minimal media (YM); however, petite yeast grew
less on YM in general (Figure 2).

To assess the transcriptional response of petite yeast to MCHM, yeast were grown in both YPD
and YM and then treated for 90 minutes with 550 ppm MCHM. 949 genes were differentially
regulated across strains and conditions (Supplemental Table 1). Gene expression levels
between petite and isogenic grande yeast were similar when grown in YPD media (only six
upregulated genes: cell wall components and iron transporters, and one downregulated gene:
putative mitochondrial protein, Figure 3A), but they were clearly different when grown in YM
(131 up and 117 downregulated genes, Supplemental Figure 1A, Supplemental Table 1). In YM,
petite yeast exhibited downregulated cell wall component genes, and there were also
significant changes on small molecule metabolism-related genes (Supp. Figure 1A, 2 and 3,
Supplemental. Table 1). MCHM treatment elicited the upregulation of genes involved in small
molecule and sulfur compound biosynthesis, among others, in both petite and grande yeast,
while the regulation of other genes differed between strains and depended on the media. For
example, genes related to nucleotide and nucleoside metabolism were upregulated in the
petite strain treated with MCHM only when grown in YM (Figure 3, Supplemental Figure 1 and
2, Supplemental Table 1). Genes downregulated due to MCHM treatment also depended on the
media (Figure. 3, Supplemental Figure 1 and 3, Supplemental Table 1). Among the genes with
variable expression due to MCHM treatment and/or the use of petite vs. grande yeast were
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several involved in zinc homeostasis (COT1, IZH1, IZH2 and IZH4, ZRT1 and ZRT2) and iron
homeostasis (ARN1 ARN2, ENB1, FIT1, FIT2, FIT3, FTR1, GGC1 and SIT1) (Figure 3, Supplemental
Figure 1 and Supplemental Table 2 and 3).

The increased expression of iron transporters was further explored given that mitochondria,
the presence of which differs between the two strains, are the site of iron-sulfur cluster protein
biogenesis. Strain ionomic profiles were evaluated for yeast strains grown in YPD. YPD was
chosen to minimize the differences in growth between grande and petite yeast. Because there
were differences in expression of cell wall genes such as CWP1, yeast were also washed in EDTA
to determine if increased iron or other metals were associated with the cell wall (water wash)
or internalized (EDTA wash). There was no difference in metal levels from yeast washed with
water alone or EDTA, indicating that the levels of reported ions were absorbed into the cells
and were not associated with the cell walls (Supplemental Figure 4 and Supplemental Table 4).
Iron levels were three times higher in petite yeast than grande yeast, while zinc was 60% lower
in the petite strain (Figure 4A). Other elements were typically higher in grande compared to
petite yeast except for calcium (Figure 4A, Supplemental Table 4), as yeast mitochondria do not
store calcium (reviewed [31]). Levels of sodium, phosphorus, and magnesium were lower in
petite yeast (Figure 4A). Copper was below the limit of detection in this analysis.

To determine if the levels of metals in yeast were changed when exposed to MCHM, yeast were
grown in YPD and then MCHM was added to a final concentration of 550 ppm. The levels of iron
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did not change for either grande or petite yeast over 90 minutes, although the strain-specific
differences noted above, were still notable (Figure 4B). mRNAs encoding siderophore
transporters such as Arn1 and Arn2 were expressed at higher levels, as were the Fit
mannoproteins, which first bind siderophores in petite yeast in YPD and MCHM compared to
wild-type yeast (Supplemental Table 3). In contrast, the levels of zinc increased two-fold in
grande yeast but did not change in petite yeast over 90 min (Figure 4C). Calcium and sodium
increased with MCHM treatment in both strains, with sodium increasing at a slower rate in the
petite yeast (Figure 4D and 4E). Potassium, phosphorus, and magnesium also increased in
MCHM treatment for grande, but not in petite, yeast (Figure 4F, 4G, and 4H). The levels of
these ions are comparable to other studies [32]. After 90 minutes of MCHM exposure, five out
of the seven ions measured were significantly higher in the grande yeast (Table 1).
Table 1. Ionomic profiles (µg/mg protein) of wildtype (S96) and petite yeast strains grown for
90 min in YPD.
Element Wildtype

Petite

P*

104.4 ±7.5

65.8 ± 2.2

K*

19.0 ± 0.45

12.3 ± 0.32

Ca

0.554 ± 0.048

0.582 ± 0.027

Mg*

11.35 ± 0.79

7.87 ± 0.25

Na

1.64 ± 0.13

1.77 ± 0.11

Fe*

0.123 ± 0.014

0.313 ± 0.014

Zn*

2.89 ± 0.24

1.17 ± 0.04

Cu

ld

ld

*Denotes significant differences between yeast strains (P<0.05).
ld = level of detection.
90

There is a significant variation of growth among genetically-diverse yeast strains in response to
MCHM. In particular, YJM789, a yeast isolated from a human lung [22], was more sensitive than
S96 at 500 ppm MCHM (Figure 5A). Using a segregant collection of YJM789 and S96 that has
been used to map genes contributing to differences in phenotypes between strains [8, 23, 24],
quantitative trait loci (QTL) analysis was carried out. The growth rate in MCHM of segregant
yeast strains was used to assess the association of various parts of the genome with increased
growth in MCHM (Figure 5B). Several peaks were noted, but only one broad peak on
chromosome nine passed the 95% confidence threshold. Within that peak, we identified YKE4,
a polymorphic gene that is a ZIP family zinc transporter [33] that plays a role in zinc
homeostasis by transporting zinc between the cytoplasm and the secretory pathway [33] and is
localized to the ER [30]. Yke4YJM789 contained two SNPs that change the protein’s amino acid
sequence (H5Q and F86L) compared to Yke4S288c (Figure 5C). The H5Q was located in the
cytoplasmic signal peptide at the N-terminus, while the F86L is at the C-terminal end of the first
transmembrane domain using TMHMM [34]. To further characterize the role of Yke4, YKE4 was
deleted from S96 and YJM789. Deletion of YKE4 did not alter growth in the presence of MCHM
in these strains (Figure 5D). The zinc levels were measured in these strains. The percentage of
zinc was normalized to wild type S96. Both YJM789 and the isogenic yke4 knockout strains had
twice as much zinc compared to S96 (Figure 5E). Yke4 is an ER-localized zinc transporter and
plays a role in intracellular trafficking of zinc and did not appear to regulate total zinc levels.
There were other genomic peaks in the QTL linked to genetic variation of MCHM response and
likely contribute to differences seen between these strains.
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To assess the contribution of other proteins involved in metal transport, we utilized the yeast
knockout collection to determine the impact of deleting MCHM differentially-regulated genes
on growth. This collection is in an S96-related strain background BY4741. In contrast to S96 and
YJM789 yeast, the yke4 mutant in this background was sensitive to MCHM (Figure 6A). There
were no significant changes in expression of YKE4 induced by MCHM (Supplemental Table 1).
However, ARN2 expression was higher in petite yeast and, from ICP-MS analysis, the
endogenous levels of iron were also higher. The BY4741 arn2 knockout was more tolerant to
MCHM (Figure 6A). The growth on MCHM of izh1 and izh2 knockouts, genes involved in zinc
transport that also were differently regulated, was not altered. Iron levels did not change with
the addition of MCHM (Figure 4B). However, zinc levels increased in the wild-type grande yeast
but not in the petite yeast with MCHM exposure (Figure 4C). We tested whether additional zinc
could alleviate the growth inhibition by MCHM. Growth improved with the addition of 10 µM of
zinc sulfate in MCHM in both BY4741 and the yke4 knockout (Figure 6B). However, at higher
zinc concentrations (100 µM), all growth was inhibited of all yeast when MCHM was added,
while zinc sulfate at this concentration alone did not alter growth (Supplemental Figure 5A).
Curiously, when zinc was added to YPD without MCHM, the media became slightly opaque.
However, after several days, media cleared around yeast colonies. YPD is an undefined media
composed of yeast extract, peptone, and agar. Zinc could have induced the precipitation of an
unknown compound or compounds that are solubilized by the growth of yeast on solid media;
the precipitation of these media components may limit yeast growth at this higher zinc
concentration. Therefore, we tested whether yeast knockouts of several known zinc
transporters would change the response to MCHM. First, the zinc tolerance of the zrt1, zrt2,
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zrt3, and zrc1 knockout yeast were tested. Only at the highest levels of zinc sulfate did the zrc1
mutant grow less than the other strains (Supplemental Figure 5A). Then, the addition of 5µM of
zinc sulfate completely rescued reduced growth in the presence of MCHM (Supplemental
Figure 5B). However, increasing zinc levels to 100µM further suppressed the growth of most of
the yeast tested grown on MCHM. The zrc1 mutant did not grow better at 5 µM and was
completely inhibited at 100 µM of zinc in the presence of MCHM. The suppression of growth in
higher concentrations of zinc was not due to the toxicity of zinc alone, as all yeast tolerated
levels up to 500 µM with only zrc1 mutant displaying reduced growth.

MCHM is composed of a saturated hexane ring with a methyl group and a methanol group at
opposite carbons (Figure 7A). The methanol and methyl group can be in the cis or trans
conformation. These characteristics of MCHM allow it to act as a hydrotrope, a compound that
can solubilize hydrophobic substances in aqueous environments. We thus considered MCHM’s
role in altering protein-membrane and protein-protein interactions, which may explain the
impacts of MCHM on the transcriptome and ionome. In vitro protein aggregation was carried
out with sodium xylene sulfate (NaXS), an industrial hydrotrope, ATP, a biologically relevant
hydrotrope [28], and MCHM. Compared to no treatment (aggregation was set at 100% for no
treatment at 45 seconds), NaXS reduced aggregation to 48% (p= 0.0064), ATP reduced
aggregation to 3% (p=0.00025), and 550 ppm MCHM treatment reduced aggregation to 60%
(p=0.02). However, at one minute of incubation, MCHM allowed full protein aggregation and
was not distinguishable from untreated controls (p=28), while NaXS and ATP continued to
prevent protein aggregation (Figure 7B). Levels of zinc sulfate that rescued MCHM-induced
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growth inhibition increased aggregation by 60% (Figure 7B). Zinc sulfate on its own caused
nearly immediate aggregation of protein which was not prevented by the addition of MCHM.
We tested if adding MCHM before zinc changed the rate of aggregation. When MCHM was
added first followed by zinc sulfate, protein aggregation showed no difference at 45 seconds
but was at the highest of all treatments tested at one minute of incubation.

Yeast have cell walls that protect cells from osmotic stress, and the cell wall can be easily
removed to produce spheroplasts. However, unlike plants and fission yeast, spheroplasted
yeast continue to divide their nuclei but don’t undergo cytokinesis [35–37], leading to large
multinucleated yeast. In this way, we can determine if hydrotropes can cause yeast to lyse
when the cell wall is not providing rigid support. SDS, a commonly used detergent, reduced the
optical density as yeast cells lysed. Sorbitol provides osmotic support and did not affect yeast
growth (Figure 7C). Treatment of spheroplasts with known hydrotropes (ATP and NaXS) did not
alter the growth of spheroplasted yeast over 15 hours, while the growth of spheroplasts
treated with MCHM was arrested but did not cause lysis (Figure 7C). The dose-dependent
reduction of spheroplasted growth likely mirrors the growth inhibition on plates with MCHM.
The growth arrest is reversible in MCHM, as cells will continue growing after MCHM is removed
(data not shown). The subcellular localization of Zrt1, Zrt2, Zrt3, and Yke4 was measured as cells
were exposed to MCHM. Proteins were tagged at the N-terminus with mCherry [30], and cells
were stained with calcofluor white to highlight the cell wall. Fluorescence of each protein
remained diffuse and no foci appeared after 90 minutes of exposure (Supplemental Figure 6A).
The endogenous promotors were replaced with a common constitutive promoter (TEF2), so any
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increased expression of Zrt1, Zrt2, and Yke4 would likely be at the protein level rather than the
mRNA level when exposed to MCHM. The protein levels of the Zrt transporters in YPD change
by no more than 20% under the TEF2 promoter, while Yke4 levels were 4-fold higher than Yke4
under its endogenous promoter [30]. Levels of ZRT1 and ZRT2 mRNAs were decreased with
MCHM (Supplemental Table 2).

Discussion
The loss of the mitochondrial DNA and treatment with MCHM had pleiotropic effects on yeast.
Petite yeast responded to stresses, including MCHM, differently than grande yeast. From RNAseq analysis, iron and zinc transporters were differentially regulated in petite yeast and grande
yeast in response to MCHM. In petite yeast, levels of zinc were lower while iron levels were
higher. Transcriptomics pointed to metal transporters, while genetic analysis uncovered genetic
variation in Yke4, an internal zinc transporter as important to MCHM. On non-fermentable
carbon sources, yke4 mutants do not grow in the presence of excess zinc [33], further
highlighting that internal zinc transport in yeast differed in many other ways. To address how
MCHM could affect the wide range of biochemical pathways seen, MCHM was tested and
shown to be a hydrotrope in vitro, which could exert cell wall or membrane stress.

Petite yeast grew slower and were especially sensitive to the growth inhibition of MCHM. This
may be in part due to the altered ionome of petite yeast. This includes higher levels of iron
from increased expression of iron transporters and lower endogenous zinc levels. These petite
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yeast were induced by loss of the mitochondrial genome, and petite yeast caused by other
types of mutations also had differences in internal metals and regulation in the iron regulome
[38]. There is an interplay between metal levels, as zinc transporters are also important for
responding to high levels of copper [24]. Zrt1 protein levels increase in response to high levels
of copper [24] and in contrast to the mRNA, Zrt1 under the control of a generic promoter and
5’UTR increased protein expressed by 66% in MCHM treatment. While genetic variation in Zrt2
contributes to copper tolerance [24], Zrt2 protein levels also increased by 26% with MCHM
exposure. Supplementation with zinc alleviates copper-induced growth inhibition as well as
MCHM growth inhibition.

The levels of sodium, calcium, phosphate, and magnesium also increased, suggesting drastic
changes at the cell wall and membrane in response to MCHM. Although mRNAs of the iron
acquisition pathway were increased in MCHM treatment, there was only a modest change in
iron levels. Other stresses, such as starvation induced by rapamycin, also induce the iron
regulon [39]. Deletion of arn2 improved growth. Arn2 is localized to the ER and suggests a role
in subcellular localization of iron in the yeast [30]. MCHM treated yeast are not starved for iron
as GTL1 and GDH3 expression was not altered. These Gtl1 and Gdh3 are iron-dependent
enzymes that are downregulated in iron-limiting media and upregulated in iron-replete media
[40]. The addition of zinc rescued growth of yeast on MCHM at low levels of zinc (5-10 µM),
while levels above 100-500 µM in combination with MCHM drastically reduced growth.
Therefore, it appears that the metals have an optimum level to ameliorate the effects of
MCHM. Based on RNA-seq and QTL analysis, two transporters of zinc were identified as having
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an important role in MCHM response. We found no correlation between levels of internal zinc
and poor growth on MCHM, possibly because subcellular localization of zinc was critical to
growth, rather than absolute levels of the metal. There could also be a period of adjustment
that could not be captured due to the differences in timepoints between measuring metal
levels and growth. Metal levels were measured at 30 minutes of exposure while growth was
measured after two days. YKE4 expression levels between YJM789 and S96 are not different in
unperturbed cells [41], and there are no SNPs in the 5’UTR or 3’UTR [42], suggesting that the
polymorphisms in Yke4 itself contributed to MCHM sensitivity in addition to other genetic
differences. While BY4741 yke4 was MCHM sensitive, deletion in S288c and YJM789 had no
effect. There are hundreds of genetic differences between BY4741 and S288c and thousands in
YJM789 [43, 44]. The pleiotropic effects of MCHM on yeast combined with the many smaller,
yet not quite statistically significant peaks in the QTL point to MCHM resistance as a polygenic
trait likely spread throughout the genome. Other yeast strains have the H5Q polymorphism,
and a subset of those also have the F86L polymorphism. To separate the role of transcription
and 5’UTR dependence, the promoter and 5’UTR of YKE4 was replaced. With MCHM treatment,
Yke4 protein levels increased 20%. 582 proteins are predicted to bind zinc with 20 proteins
binding 90% of total cellular zinc [45] and zinc sparing ensures that essential Zn binding proteins
have zinc. As YJM789 expresses less Zrt1 protein normally [24], perhaps the internal levels of
zinc and the ability of the yeast to quickly redistribute the zinc in MCHM may alter their ability
to grow.
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Hydrotropes in cells prevent protein aggregation, but unlike surfactants, work at millimolar
concentrations and display low cooperativity. In addition to changes in protein levels, posttranslational modifications, subcellular location, and changes in protein conformation also
regulate protein function. Protein aggregation is generally thought to inactivate proteins.
Protein aggregation includes prions, which increase phenotypic plasticity without changing
genetic diversity [46]. Intrinsically disordered regions of protein can separate proteins without
being membrane-bound, which is an important step in RNA granule formation [47].
Transmembrane domain proteins such as Zrts, Yke4, and Arn transporters have multiple
extracellular and intracellular loops that would be also disordered regions. MCHM slowed the
aggregation of proteins in an in vitro assay, but with added zinc sulfate, which on its own
induces some protein aggregation, MCHM appeared to combine to increase the rate of
aggregation rather than preventing it. MCHM showed similar hydrotrope activity to NaXS, an
industrial hydrotrope, but it was not as potent as ATP. Transcriptomics carried out after 90
minutes, approximately one generation in yeast, detected changes in mRNA encoding metal
transporters. Zinc is required for both the synthesis of cell walls and phospholipids [33, 48].
Exposure of yeast to MCHM increased intracellular sodium levels yet yeast do not actively
accumulate sodium [49], further supporting that MCHM alters the protein structures to either
increase the bioavailability of ions or transport across cell membranes. MCHM altered the
levels of ions in the cell at the earliest time points. Therefore, we conclude that this is likely
through altered protein conformation at the cell membrane of many proteins because of the
diverse metals that changed during MCHM exposure. Proteins and organelles are increasingly
found in altered conformations to change local concentrations of proteins in (reviewed [50]).
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Inside the cell, MCHM could alter how molecules interact in liquid droplet changing the
function of protein functions and metabolites in the cell.
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Figures:

Figure 1 Schematic of yeast cellular response to varying levels of zinc. Under low intracellular
zinc levels, Zap1 induces expression of zinc uptake genes. Zrt1, the high-affinity, and Zrt2 the
low-affinity transmembrane zinc transporter, are localized in the cell membrane. Izh1 and Izh4
localize to the cytoplasmic side of the cell membrane and regulate zinc homeostasis. Excess zinc
(blue hexagons) is stored in the vacuole and transported in by Zrc1 and Cot1. Excess zinc is
stored in the vacuole, and when needed, Zrt3 transports zinc to the cytoplasm. In addition to
the vacuole, the ribosome (red circles) bind 20% of total cellular zinc [45]. Yke4 is the
transmembrane transporter at the ER (pink and purple) that transports zinc in both directions.
Sod1 is the copper-zinc super oxygen dismutase that is both cytoplasmic and localizes to the
inner mitochondrial membrane. (Jennifer Gallagher made model figure)
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Figure 2 Serial dilution of wild-type S96 and petite yeast in increasing concentration of MCHM
in rich (YPD) and minimal (YM) media. Plates were incubated at 30oC for three days and then
photographed. (Jennifer Gallagher did petite/grande yeast growth assays)
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Figure 3 Changes in RNA expression between wild type and petite yeast grown in YPD treated
with MCHM. The number of up- and downregulated genes is noted on the top of each panel.
(A) Scatter plots of log fold 2 comparisons of RNA-seq from grande (S96) and petite (S96ρ) yeast
grown in YPD. Significantly upregulated genes are labeled in red and significantly
downregulated genes are labeled in blue. (B) Scatter plots of log fold 2 comparisons of RNA-seq
grande yeast grown in YPD and with 550 ppm MCHM. (C) Scatter plots of log fold 2 comparisons
of RNA-seq from petite yeast grown in YPD and with MCHM. (D) Scatter plots of log fold 2
comparisons of RNA-seq from S96 and S96 yeast grown in YPD and with MCHM. (Amaury Pupo
performed differential expression analysis)
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Figure 4 Measurements of metals in yeast treated with MCHM (A) Levels of Fe, Zn, Ca, Na, Mg,
K and K in µg/mg from grande (S96) and petite (S96ρ) yeast grown in YPD. Levels of metals from
grande (S96) and petite (S96) yeast grown in YPD with 550 ppm MCHM added for the
indicated time. The ions levels measured were (B) Fe, (C) Zn, (D) Ca, (E) Na, (F) Mg, (G) K and (H)
F. The standard error is noted on the mean of four biological replicates. (Jennifer Gallagher and
Jonathan Cumming performed ICP analysis)
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Figure 5 Genetic variation of MCHM response linked to the YKE4 locus. (A) Serial dilution of
genetically diverse yeast on 550 ppm MCHM on YPD. S96 are from the S288c background and
YJM789 is a clinical isolate. (B) Quantitative trait loci analysis of chromosomal regions linked to
increased growth of yeast in MCHM from YJM789 and S96 segregants. (C) Diagram of Yke4
describes the transmembrane domains (TM noted with grey box) and inside or outside domains
(noted with lower dark grey or upper light grey lines, respectively). Polymorphic residues are
noted below in Yke4YJM789 compared to Yke4S288c. The conserved ZIP domain is boxed in a grey
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dashed line. (D) Serial dilutions of S96 and YJM789 with yke4 mutants on MCHM. (E) Levels of
total intracellular zinc from S96, YJM789 and yke4 mutants normalized to S96 grown in YPD and
total protein. Yeast were incubated with 5 µM zinc sulfate, 550 ppm MCHM and in combination
for 30 minutes before metals were extracted. (Michael C. Ayers performed yeast growth assay
and phenotyping and computational analyses for QTL in parts A through C. Michael C. Ayers
constructed yeast knockout strains and performed growth analyses in part D. Jennifer Gallagher
and Jonathan Cumming performed ICP analysis of yeast strains from part D in part E.)
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Figure 6 Impact of loss of metal transporters on growth with MCHM and zinc-containing
media. (A) Serial dilution of BY4741 and yeast from the knockout collection on YPD with 400
ppm MCHM. (B) Serial dilution of wild type (BY4741) and zinc transporters knocked out yeast
grown in 400 or 550 ppm MCHM on YPD with 10µM zinc sulfate. (Michael Ayers performed all
experiments.)
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Figure 7 MCHM role in protein aggregation. (A) Chemical structure of the cis and trans
conformation of MCHM. (B) Timed protein aggregation when exposed to heat. No treatment is
compared to 10 mM sodium xylene sulfate, 1mM ATP, and 550ppm MCHM. The optical density
of samples was measured at 450nm after incubation at 60°C. 550 ppm MCHM was added to
samples then 10 M zinc sulfate was added where indicated. (C) Spheroplast yeast were
incubated for between 0 and 15 hours with 0.1% SDS, 0.5% water, 10 mM sorbitol, 1 mM ATP,
10 mM NaXS, 10 µM zinc sulfate and 550-1000 ppm MCHM and samples were read at 600 nm.
Biological quadruplicates were averaged and standard error. Relevant p values were calculated
using the student t-test. (Zachary Sherman performed protein aggregation and Tecan growth
experiments in parts B and C.)
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The following Supplemental Materials are available at
https://link.springer.com/article/10.1007/s12011-019-01850-z#Sec13 for download.
Supplemental Table 1. Comparisons of RNA-seq from S96 and S96 petite yeast treated with 550
ppm MCHM for 90 minutes in YPD and YM supplemented with lysine.
Supplemental Table 2. Comparisons of zinc related genes from S96 and S96 petite yeast treated
with 550 ppm MCHM for 90 minutes in YPD and YM supplemented with lysine.
Supplemental Table 3. Comparisons of iron related genes from S96 and S96 petite yeast
treated with 550 ppm MCHM for 90 minutes in YPD and YM supplemented with lysine.
Supplemental Table 4. Levels of metals from S96 grande and petite yeast treated with 550 ppm
MCHM grown over 90 minutes in YPD. The mean of four biological replicates is shown with
standard error. Levels of metals washed with water compared to yeast washed with EDTA.
Supplemental Figure 1. Scatter plots of log fold 2 comparisons of RNA-seq from grande S96
and petite S96 yeast grown in YM supplemented with lysine. Significantly upregulated genes
are labeled in red and significantly downregulated genes are labeled in blue. (A) Scatter plots of
log fold 2 comparisons of RNA-seq petite and grande yeast grown in YM. (B) Scatter plots of log
fold 2 comparisons of RNA-seq grande yeast grown in YM and with 550 ppm MCHM. (C) Scatter
plots of log fold 2 comparisons of RNA-seq from petite yeast grown in YM and with MCHM. (D)
Scatter plots of log fold 2 comparisons of RNA-seq from grande and petite yeast grown in YM
and with MCHM. (Amaury Pupo performed analyses on transcriptome data.)
Supplemental Figure 2. GO term analysis of genes upregulated in all pairwise comparisons
with single variable between S96 grande and S96 petite yeast grown in YM and YPD with
MCHM added. The color scale of p adjust values are noted and the size of the circle notes gene
ratio. The number of genes in each comparison is noted in parentheses. (Amaury Pupo
performed analyses on transcriptome data.)
Supplemental Figure 3. GO term analysis of genes downregulated in all pairwise comparisons
with single variable between S96 grande and S96 petite yeast grown in YM and YPD with
MCHM added. The color scale of p adjust values are noted and the size of the circle notes gene
ratio. The number of genes in each comparison is noted in parentheses. (Amaury Pupo
performed analyses on transcriptome data.)
Supplemental Figure 4. Levels of Fe and Zn in grande and petite S96 yeast washed with water
and EDTA or with only water before metal extraction. Mean of four biological replicates are
shown with standard error. (Jennifer Gallagher and Jonathan Cumming performed ICP.)
Supplemental Figure 5. Role of zinc transporters in MCHM response with supplemented zinc.
(A) Serial dilution of wild-type (BY4741) and zinc transporter knockout yeast were grown on
YPD supplemented with increasing concentrations of zinc sulfate. (B) Serial dilution of wild-type
(BY4741) and zinc transporter knockout yeast grown in 400 ppm MCHM on YPD supplemented
with increasing concentrations of zinc sulfate. (Michael C. Ayers performed yeast knockout
growth assays.)
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Supplemental Figure 6. Levels of mCherry tagged Zrt1, Zrt2, Zrt3, and Yke4 proteins change
with MCHM exposure. Yeast were exposed to 550 ppm of MCHM in YPD for 30 minutes. (A)The
cell wall was stained with calcofluor white. (B) The mean fluorescence of mCherry normalized
to untreated yeast for each protein. Quantification for 17-20 cells shown with standard error.
(Zachary Sherman performed mCherry tagged yeast growth assays.)
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Abstract
Cell changes in response to the coal-cleaning chemical 4-methylhexanemethanol (MCHM) have
previously been shown to involve nutrient and oxidative stress responses, metal homeostasis,
and membrane sterol content control. MCHM acts as a hydrotrope, affecting the folding and
aggregation of proteins and membrane stability. Nonetheless, the information gleaned from
affected pathways has not provided a unifying mechanism sufficient to induce resistance. We
produced eight strains of S. cerevisiae resistant to MCHM by using In-Lab evolution from a
single YJM789 parent strain, and we analyzed the genomic changes that provided this new
resistant phenotype. We identified thousands of SNP and indel variants per strain, which was a
consistent number between strains that evolved resistance and control strains that remained
sensitive. These variants did not show a pattern that would cluster resistant strains together.
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The many background mutations likely masked any pattern from few large-effect loci or
implicated an epistatic effect of many small mutations spread throughout the genome that was
undetectable. Among coding variants in the strains which change protein sequence and thereby
may alter function, only one gene showed a protein-coding mutation in every resistant strain
while showing no variants at all in the control strains. This gene, PDR3, controls transcription
for the pleiotropic drug response and is likely the most significant driver of adaptive MCHM
resistance in yeast. While many of the evolved alleles of PDR3 would likely produce functional
proteins, a knockout in the parent YJM789 strain was sufficient to produce resistance to
MCHM. This transcription factor is the first gene where mutations are known to increase
resistance to this novel hydrotropic chemical.
Introduction
The chemical 4-methylcyclohexanemethanol (MCHM) came to relevance when a crude
formulation used in coal-cleaning processes spilled into the Elk River outside Charleston, WV in
January 2014. The spill affected the drinking water of approximately 300,000 residents, so
research became widespread to characterize everything from the volatility and adsorption
properties of the chemical in water systems to the toxicological effects on various model
organisms (Han et al., 2017; Horzmann et al., 2017; Phetxumphou et al., 2016; Sain et al., 2015;
Weidhaas et al., 2016; West Virginia Chemical Spill: Collective NTP Findings and Supporting
Files, n.d.). The cellular biological effects of the chemical have been explored in more detail in
yeast than in other organisms.

118

More recent work has produced genomic datasets to determine the cellular pathways involved
in MCHM response. MCHM is a hydrotrope which affects protein folding and has been
implicated to have a role in zinc ion concentration changes in the cell to alleviate this stress
(Pupo, Ayers, et al., 2019). Lipid biosynthetic changes induced by MCHM may also be a source
of stress on the plasma membrane (Pupo, Ku, et al., 2019). MCHM also causes amino acid
accumulation according to metabolic data, while exhibiting a nutrient starvation signal
activating the environmental stress response (Ayers et al., 2020; Pupo, Ku, et al., 2019). One
early study using stress gene reporters showed oxidative stress and DNA damage response
activation in response to MCHM and its potential metabolites (Lan et al., 2015). The more
recent work using yeast genomic datasets confirmed MCHM causes the production of reactive
oxygen species (ROS) in yeast cells, as well as DNA damage, making yeast strains sensitive to
ROS, such as petite yeast, unable to grow (Ayers et al., 2020; Lan et al., 2015; Pupo, Ayers, et
al., 2019). This data all points to widespread cellular pathways important for MCHM tolerance.
In-Lab evolution (ILE) of yeast is a tool that allows for the genetic analysis of many
phenotypes and processes of evolution. The short generation time of yeast allows for the quick
production of large populations that accumulate mutations that may respond to selection or
drift in the lab. This has been used to experimentally observe evolution in industrial
environments with yeast hybrid strains to determine if they evolve similarly in terms of
aneuploidy and copy number to historical lager brewing yeast hybrids (Gorter de Vries et al.,
2019) and with wine strains where ploidy events control significant changes in fermentation
efficiency (Mangado et al., 2018). Experiments also explore processes such as yeast and
bacterial populations in competition and yeast populations that converge towards phenotypes
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with similar fitness due to epistatic interactions of beneficial mutations (Kryazhimskiy et al.,
2014; Zhou et al., 2018). To understand stress resistance, ILE has been used to produce yeast
adapted to a multitude of stressors. Adaptation to copper has been produced in S. cerevisiae
and Candida humilis, revealing mechanisms such as overexpression of superoxide dismutases
and catalases to detoxify ROS and overexpression of proteins that bind excess copper (Adamo
et al., 2012). Thermotolerance was also evolved in yeast stains to explore mechanisms that
could improve industrial biomass to ethanol conversion processes. Cellular changes involving
sterol components of the membrane and concentrations of glycerol also provided increased
tolerance to stresses from osmolarity and excess glucose and ethanol (Caspeta & Nielsen,
2015). The evolution of resistance to a glyphosate-based herbicide in the lab was shown to
involve copy number changes in proteins affecting cell wall stability in response to the
presumably inert non-glyphosate additives in the herbicide (Ravishankar et al., 2020). ILE
experiments are an unbiased and insightful method for understanding specific mechanisms and
processes of adaptation to environments.
Yeast cells use the pleiotropic drug response to detoxify and remove a multitude of
general xenobiotics and chemical stressors. Much of the work of this response is performed by
a class of proteins called ATP-binding cassette (ABC) transporters that translocate chemicals out
of the cell and are a conserved group of proteins throughout the tree of life (reviewed by
Jungwirth & Kuchler, 2006). Some important stress-responsive yeast ABC transporters include
Pdr5, Snq2, Pdr15, and Yor1, all of which have roles in exporting drugs or various chemically
unrelated toxic chemicals out of the cell in response to stress (Balzi et al., 1994; Bissinger &
Kuchler, 1994; Jungwirth & Kuchler, 2006; Katzmann et al., 1999; Kolaczkowski et al., 1998;
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Servos et al., 1993; Wolfger et al., 1997; Wolfger et al., 2004). The transcriptional control of the
genes encoding these proteins involves the interplay of the transcription factors Pdr1 and Pdr3,
two paralogs sharing 36% amino acid sequence similarity along the entire length of the proteins
(Delaveau et al., 1994). These proteins form heterodimers and homodimers that compete to
occupy cis-regulatory elements termed PDREs upstream of pleiotropic drug response genes
(Katzmann et al., 1996; Mamnun et al., 2002). Their interaction in different combinations and
on PDREs of different genes likely plays a role in the relative inhibition and activation of these
same genes (Mamnun et al., 2002). The importance of the ABC transporters in a cell’s response
to chemical stressors is important for evolved stress adaptation. In particular, induced
mutagenesis experiments on PDR3 have produced activated gain-of-function alleles where Pdr3
increases the expression of PDR5 and SNQ2 and increases resistance to a multitude of
chemicals (Nourani et al., 1997; Simonics et al., 2000). The role of the ABC transporters in the
response to chemical stress makes them and the proteins that control their expression targets
for adaptation to chemicals such as MCHM.
In this study, we utilized In-Lab evolutions to produce strains adapted to the spill
chemical MCHM. The goals of the study were to identify mechanisms as yet uncovered in the
cellular response to MCHM as well as explore the evolutionary process under novel stress that
yeast were unlikely to have encountered in their environmental niche. Eight strains evolved in
MCHM became resistant to high dosages of the chemical, while the eight control strains
evolved under similar conditions without MCHM remained sensitive. All 16 strains accumulated
similar numbers of mutations overall. There were no clear patterns in mutations that led to
resistance, except for variants appearing in the gene PDR3. The mutations in this gene were the
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major reproducible drivers of resistance to MCHM, but other mutations spread across the
genome likely contributed to the convergent phenotype through epistatic interactions of small
effects.
Materials and Methods
In-Lab evolutions:
The YJM789 strain (MATalpha, lys2∆) (McCusker et al., 1994b, 1994a; Tawfik et al.,
1989; Wei et al., 2007) was grown in biological quadruplicate in 2mL liquid cultures of YPD (1%
yeast extract, 2% peptone, 2% dextrose) media with and without 700ppm crude MCHM at 30°C.
Cultures were grown for two days before 1% of the culture was used to inoculate fresh tubes
containing 2mL of YPD or YPD+700ppm MCHM media. This passaging process was performed
for six passages before plating serial dilutions onto YPD plates containing ranges of 0-1000ppm
MCHM. Two colonies were isolated from each final evolved population. The isolates were
grown for 2-3 passages in liquid YPD without MCHM to allow for removal of epigenetic memory
of resistance that may impact growth on MCHM media. The resistance of the 16 isolated
strains, eight control evolutions, and eight MCHM evolutions, was evaluated by growing on
1000ppm MCHM solid media (YPD as above, plus 2% agar). Following the epigenetic check
consisting of passaging isolates in the absence of MCHM then rechecking for continued
resistance, genomic DNA was then isolated from the strains and submitted for sequencing at
the WVU Genomics Core as previously (Ravishankar et al., 2020).
Sequencing and analysis:
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Strains were sequenced on an Illumina Miseq producing 151bp paired-end reads of
between 1,638,426 and 3,445,498 reads per strain. Raw sequence reads and vcf files produced
by the mapping and variant calling analysis are available on figshare at the following DOI link:
10.6084/m9.figshare.13028222. Reads were aligned to the S288c reference genome R64.2.1
release obtained from yeastgenome.org (Engel et al., 2013) using BWA version 0.7.17-r1188 (Li
& Durbin, 2009), giving coverage of approximately 20-30x across the genome for each strain.
SAM and BAM files were created using samtools version 1.7 (Li, 2011; Li et al., 2009). Variants
were called using the HaplotypeCaller function of GATK 4.1.6.0 (Van der Auwera et al., 2013) on
Java Runtime Environment 11.0.6. Variants were filtered by removing all variants that did not
pass GATK quality measures. As YJM789 has approximately 60,000 SNPs (Wei et al., 2007) when
compared with the S288c reference, these variants were removed by filtering all variants that
were shared amongst all 16 evolved strains (control and MCHM) and using an existing SNP list
for the strains. Any variants shared by all 16 strains were assumed to be existing variation
between S288c and YJM789, as opposed to random mutations that happened in every sample.
The 6874 remaining variants in the 16 strains were analyzed for presence in coding regions and
the intersection between strains as below. The numbers of variants per strain in the eight
control strains and eight MCHM strains were compared with a two-tailed Student’s T-test to
determine if there was any difference in total number of variants between resistant
phenotypes.
Variants were analyzed further using R version 3.6.3 and the following packages:
VariantAnnotation version 1.32.0 (Obenchain et al., 2014), pcadapt 4.3.1 (Luu et al., 2020),
BSgenome.Scerevesiae.UCSC.sacCer3_1.4.0 (Pagès, 2019; Team, 2014),
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TxDb.Scerevisiae.UCSC.sacCer3.sgdGene_3.2.2 (Carlson & Maintainer, 2015), and all
dependencies are available in Supplemental Table 1. The entire R analysis script and
supplemental files and tables are available at https://github.com/wvumayers/MCHM.git. In
short, the 6874 variants that remained following filtering were analyzed for PCA clustering
analysis using the pcadapt package with a k=3 based on screeplot. Variants were also plotted
for their density across the genome by first creating a table of approximately 40000 variants by
including every instance of the 6874 unique variants in all 16 strains, as many variants appeared
in multiple strains. A second plot was made with variants shared by less than 10 strains,
reducing the table to approximately 15000 variants across all strains from 4968 unique variants.
The plots were produced using 2.5kb windows in the karyoploteR package, version 1.14.1, in R
on the sacCer3 genome (Gel & Serra, 2017). Variants then were filtered to remove all those
found in any of the control strains, regardless of presence in the MCHM strains. This left 1171
variants existing only in at least one of the eight MCHM evolved strains. These variants were
analyzed for their effect on coding sequences using the predictCoding command of the
VariantAnnotation package and the UCSC sacCer3 genome and transcript packages mentioned
above. There are three protein/ORF annotation differences between the sacCer3 version of the
genome and the S288c R64.2.1 version of the genome used to map the original sequences and
call variants that did not affect the coding predictions of this dataset. The SIFT 4G variant
annotator software was also used to determine the predicted tolerance score for each variant
from the original ILE vcf files (Vaser et al., 2016). The Saccharomyces cerevisiae R64-1-1.23
database included with the SIFT4G jar was used to annotate the variants.
GO terms and intersection of strain variants:
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GO terms for the 107 genes that contained nonsynonymous and synonymous variants in
the MCHM evolved strains were determined using the DAVID bioinformatic database at
https://david.ncifcrf.gov (Huang et al., 2009a, 2009b). Default options were used for the
analysis. The intersection analysis of strains containing the same genes was performed using
the shiny app tool version of UpSetR at https://gehlenborglab.shinyapps.io/upsetr/(Lex et al.,
2014).
PDR3 knockouts and allele analysis:
The YJM789 PDR3::NAT knockout was produced by transforming PCR construct
containing the NATR gene amplified from the pAG25 plasmid (Goldstein & McCusker, 1999)
using the following primers: forward 5’GCATCAGCAGTTTTATTAATTTTTTCTTATTGCGTGACCGCAACGGATCCCCGGGTTAAT-3’ and reverse
5’-TACTATGGTTATGCTCTGCTTCCCTATTTTCTTTGCGTTTGAATTCGAGCTCGTTTAAAC-3’. All
transformations were performed using lithium acetate, as described previously (Gietz &
Schiestl, 2007). Colony PCR confirmation of the knockout cassette integration was performed
using the following primers: forward 5’- TCCAAAGCAACCATAGGTC-3’ and reverse 5’ATGTACGGGCGACAGTCACATCAT-3’. Serial dilution growth assays for resistance phenotyping of
the knockout were performed on solid MCHM YPD media as above and compared to growth of
the BY4742 knockout collection knockout of PDR3 as well (Brachmann et al., 1998; Giaever et
al., 2002).
Results
In-Lab evolution of YJM789 in MCHM:
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Previous studies of MCHM’s effects on yeast cells used genetic knockouts,
transcriptomics, metabolomics, and biochemical assays to determine that MCHM resistance is
dependent on a complex interaction of many cellular and genetic networks (Ayers et al., 2020;
Pupo, Ayers, et al., 2019; Pupo, Ku, et al., 2019). To expand upon this knowledge, resistant
strains were developed through In-Lab evolution (ILE) experiments to help elucidate genetic
changes that might produce a new resistant genotype. There is considerable genetic variation
across different yeast strains that may affect resistance to chemicals. Previously, a mapping
population between S96 (an S288c laboratory strain) and YJM789 (a clinical isolate) uncovered
standing genetic variation that is linked to MCHM response (Pupo, Ayers, et al., 2019). S96 is
more MCHM resistant than YJM789, and we used these strains to select for increased MCHM
resistance. Four replicates of each strain were evolved in rich liquid YPD media with and
without 700ppm MCHM (Figure 1A). The lineages of the original eight samples (four control,
four treated) were passaged every two days for six passages. Control and treated lineages were
plated after the sixth passage, and two single colonies were isolated from each lineage to
produce eight total control strains and eight total treated strains. After six passages, the MCHM
treated strains grew faster than the earlier passaged. However, this was only seen in the
YJM789 cultures, and increased MCHM resistance in S96 strains did not develop after multiple
attempts (not shown). S96 was already more MCHM resistant than YJM789 and further
resistance could not be achieved in the ILEs. We continued with YJM789 strains. These YJM789
strains were named S1-16, with S1-8 being the control strains (and S1 and S2 being from the
same original lineage), and S9-16 being the treated strains (and S9 and S10 being from the
same original lineage). The 16 strains were tested for their MCHM resistance at 1000ppm on
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YPD media. The eight control strains showed wildtype levels of resistance, while all eight
treated strains showed increased resistance as compared to wildtype (Figure 1B). There was
plate to plate variation in MCHM at 1000ppm, likely due to nearing the solubility limit of the
chemical (Dietrich et al., 2015; Phetxumphou et al., 2016; Sain et al., 2015). The wildtype strain
was plated on each plate to control for plate to plate variation (Figure 1B).
Principal component analysis of mutations:
After successfully producing resistant strains of evolved YJM789 yeast, the 16 samples
were sequenced at approximately 25x coverage using Illumina paired-end reads. The reads of
all 16 strains were mapped to the S288c reference genome and variants were called using GATK
HaplotypeCaller. After removing the variants shared between all 16 strains, considered to be
the existing variants between the reference genome and the YJM789 genetic background,
variants were clustered on three principal components (Figure 2A-C). To analyze whether there
may be a general pattern of evolved resistance in the remaining variants, a PCA analysis was
performed. The strains did not cluster according to resistance on any of these components. As
an aside, they also did not cluster by original lineage, so none of the pairs (individual isolates
from the same population), such as S1 and S2 or S9 and S10, clustered. This indicates the
colonies isolated from the same cultures were genetically distinct. A large number of remaining
background variants, approximately 6900 (Table 1), likely prevented clustering by resistance
phenotype because there are too many variants in the analysis that are non-causative for
resistance. A few high effect loci would be masked by large numbers of non-causative variants.
Similarly, resistance spread among many lower effect loci spread throughout the genome
would also be masked if resistance in each strain was due to different combinations of these
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small effects. In total, looking at the sum of variants produced by the In-Lab evolution
conditions did not produce clear patterns of resistance. The mutation patterns of the MCHM
and control strains showed there was no significant difference in the number of variants in
control vs. MCHM ILEs (p = 0.15) and all 16 strains had between 2326 and 2681 variants per
strain (Table 1). The total number of mutations does not seem to be from any effect of the
chemical.
Table 1: Summary of mutated genes in ILE strains. This table contains the number of overall
mutations and mutated genes in each ILE strain. Ty retrotransposon genes, such as gag/pol
domains, were excluded from this analysis.
Strain Total
mutations
(6874
total)

MCHM specific
mutations only
(1171 total)

Mutations
in coding
regions –
Excluding
Ty

Genes with
mutations
(107)

Nonsynonymous Genes with
mutations only
Nonsynonymous
mutations (75)

S1

2550

S2

2543

S3

2681

S4

2516

S5

2436

S6

2657

S7

2521

S8

2471

S9

2579

212

54

25

33

16

S10

2496

187

63

28

31

18

S11

2493

180

43

24

20

16

S12

2415

187

53

25

28

16

S13

2512

189

59

33

35

23

S14

2475

170

64

33

42

20

128

S15

2572

180

53

24

34

18

S16

2326

170

45

25

25

15

Filtering MCHM evolved variants to those involved in coding sequence changes:
To find patterns of mutations that contributed to MCHM resistance, we considered
variants shared by both the control ILE and the MCHM resistant strains were likely to be
passenger mutations and not causative of the MCHM resistance phenotype. These mutations in
the control ILE strains were filtered from the variants in the eight resistant ILEs. This left 1172
variants between the eight treated ILE strains (Table 1). Many of these variants were in noncoding regions of the genome, and while they could contribute to resistance to MCHM through
changes in expression levels of genes, mutations in intergenic regions were filtered out, leaving
485 variants in genes between the eight strains (Table 1). The final filter used to narrow the
focus to those that may be causative of resistance was to remove variants in Ty
retrotransposon Gag/Pol proteins. The YJM789 strain does not contain the same Ty
complement as the S288c reference strain (Wei et al., 2007). Therefore, the detection of these
variants is likely due to the existing variation between the parent strain of the ILEs and the
reference. The reason they remained after using earlier filters that removed all variants shared
between the 16 ILEs, and a filter containing known SNPs in YJM789, is due to issues of 25x
coverage with short reads not able to detect repetitive regions and large deletions. These final
filters were supported by analysis of variant density across the genome (Supplemental Figure
1). This analysis plotted the location of variants for all 16 strains based on chromosomal
location. With many of the 6800 variants being shared amongst multiple strains, sometimes up
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to 15 strains, approximately 40000 variants were plotted initially (Supplemental Figure 1A).
When filtering out variants shared by 10 or more strains, 4900 unique variants remained
instead of 6800, resulting in plotting 15000 variants total across the 16 strains instead of 40000
(Supplemental Figure 1B). The differences in these plots include a region on chromosome VIII
around 90kb that corresponds to a Ty region in S288c that is missing in YJM789. These parental
variants were picked up in most strains, but not all. Filtering down to those variants shared by
less than 10 strains minimized the effect of missed parental variants on the analysis. The
removal of all variants existing in control strains, leaving the 1172 variants analyzed for coding
effects in MCHM strains, removed these variants. After removing Gag/Pol Ty retrotransposon
detected variants, there were between 45 and 64 variants per strain in the eight strains,
contained in 107 total genes (Table 1 and Supplemental Table 2). Finally, limiting our analysis to
nonsynonymous coding changes left between 20 and 42 variants per strain, contained in only
75 genes (Table 1 and Supplemental Table 3).
In order to analyze the intersection of these 75 genes with nonsynonymous changes
between strains, UpSetR software was utilized (Lex et al., 2014). Each strain contained
nonsynonymous variants in three to seven genes that were exclusive to that individual strain
(Figure 3A). This accounted for 42 of the genes containing variants in the MCHM evolved
strains, so more than half of genes with variants were found to have variants in multiple strains.
An additional 18 genes contain variants in two strains. The remaining 15 genes contained
variants within at least three strains, but only one gene was found to have a nonsynonymous
variant in all eight strains (Figure 3A). This gene was PDR3 (Figure 3A), a transcription factor
that controls the expression of ABC transporters involved in the pleiotropic drug response
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which exports chemicals from the cell that are involved in general stress (Delaveau et al., 1994).
When the intersection of all 107 genes containing nonsynonymous or synonymous variants was
analyzed, PDR3 remained the only gene with a variant in all eight MCHM ILE strains
(Supplemental Figure 2, Table 2).
Table 2: Summary of genes containing unique variants in at least four MCHM ILE strains. This
table shows a list of genes that appear in at least four MCHM ILE strains with an MCHM-unique
variant. Uncharacterized ORFs have no annotated function in yeast but may produce functional
proteins. Dubious ORFs are unlikely to produce functional proteins. The last two columns show
how many MCHM and control ILE strains contain any variant at all in the gene, including
variants that appear in both MCHM and control strains. These columns are included to show to
what extent this gene seems to accumulate variants overall. Total number of variants is in
parentheses in the last two columns, as some strains contain multiple variants in that gene.
MCHM ILEs
Containing
ORF
Unique
CharacterVariant(s)
ization
in this
Gene

MCHM
ILEs - any
Variant

Control
ILEs - any
Variant

Chr

[genes
(variants)]

[genes
(variants)]

AGP3

4

Verified

chrVI

17004

18680

4 (13)

3 (10)

COS4

5

Verified

chrVI

6426

7565

7 (36)

6 (22)

FLO1

4

Verified

chrI

203403

208016

8 (187)

8 (280)

HPF1

4

Verified

chrXV

28703

31606

8 (96)

8 (111)

HXT13

4

Verified

chrV

21537

23231

8 (61)

8 (60)

HXT17

5

Verified

chrXIV

772657

774351

6 (16)

4 (5)

HXT9

5

Verified

chrX

19497

21200

7 (13)

5 (19)

PAU24

4

Verified

chrII

809057

809419

7 (24)

7 (10)

PDR3

8

Verified

chrII

217470

220400

8 (8)

0 (0)

SAM3

4

Verified

chrXVI

22938

24701

7 (20)

8 (29)

TPO2

5

Verified

chrVII

763762

765606

5 (6)

0 (0)

YAL069W

7

Dubious

chrI

335

649

8 (91)

8 (97)

Gene Name
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Start

End

YCR108C
YEL077C

6
4

Uncharacteri
zed

chrIII

315997

Uncharacteri
zed

chrV

264

4097

chrV

630

1112

4

Dubious

YER188C-A

4

Uncharacteri
zed

chrV

569608

569907

Uncharacteri
zed

chrXIV

599936

601774

Dubious

chrXIV

7165

7419

YNL337W

4
4

8 (26)

8 (44)

8 (63)

5 (16)

3 (7)

8 (68)

8 (56)

8 (67)

8 (64)

7 (18)

6 (12)

316188

YEL077W-A

YNL018C

8 (36)

To determine if mutations in any cellular process might be important for evolved MCHM
resistance, the 107 genes containing at least one variant in at least one MCHM ILE strain,
including synonymous variants, were analyzed via GO Term analysis (Figure 3B). Most GO terms
pointed to mutations in plasma membrane (FDR = 0.0096%) or cell wall proteins (FDR = 5.85 x
10-5%), including those important for sugar transport or flocculation (Figure 3B). In agreement
with previous genomic work with MCHM, the vacuole (FDR = 0.21%) and response to stress
(FDR = 0.19%) also contained mutations that may impact resistance (Ayers et al., 2020).
To find only mutations that directly contributed to MCHM resistance, we focused on genes that
contained mutations in multiple isolates. There were 18 genes with at least one synonymous or
nonsynonymous variant not found in control strains within their coding regions in four or more
MCHM ILEs (Table 2). However, many of these genes also seem to accumulate a high number of
mutations in the rich liquid media culture environment. This is exemplified by FLO1, where all
16 strains contained variants, 467 in total. Some genes in the list accumulate more variants,
possibly through their position near the ends of chromosomes where mutation rates are known
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to be higher (Agier & Fischer, 2012; Ivanova et al., 2020; Lang & Murray, 2011) and/or reduced
selective pressure on their function in laboratory growth media. Only two genes showed no
mutations in any of the eight control ILE strains while also showing mutations in at least half of
the MCHM ILEs, PDR3, and TPO2.
The list included seven uncharacterized or dubious ORFs, mostly found at the ends of
their respective chromosomes (Table 2). The unknown or nonexistent function of these genes
made them unlikely candidates for adaptive resistance mechanisms. The remaining genes’
functions varied, but most were membrane or cell wall proteins (FLO1, HPF1, PAU24), often
involved in sugar or nutrient transport (AGP3, HXT9, HXT13, HXT17, TPO2). These cell wall
genes, as well as stress response genes such as PDR3, may be situated as targets of adaptive
changes for MCHM resistance due to their changes that may decrease the internal cellular
concentration of the chemical.
Prediction analysis for the tolerance of protein-coding changes from variants in MCHM ILEs:
Because there were thousands of variants per strain, including dozens of variants in
coding regions of each MCHM ILE, all mutants unique to the MCHM resistant strains were
scored as deleterious or well tolerated for protein function. SIFT analysis predicts whether
amino acid substitutions from single nucleotide polymorphisms will be tolerable for protein
function using multiple sequence alignment of homologous protein sequences (Vaser et al.,
2016). The variants in our dataset included both SNPs and indels, but indel variants could not
be scored because SIFT exclusively analyzes SNPs. We also analyzed our genome for CNVs but
none were detected in the evolved strains. Most of the variants were predicted to be tolerated

133

(Table 3 and Supplemental File 1). There are two reasons this may be the case. First, many of
these variants are synonymous with coding changes, so SIFT analysis will align proteins and
predict no deleterious effect based on conservation. That does not eliminate the possibility that
the proteins’ expression levels change due to codon bias changes (Bennetzen & Hall, 1982;
Letzring et al., 2010; Presnyak et al., 2015), but these synonymous changes are less likely to be
the major drivers of resistance change than protein sequence changes. The second reason most
of these variants would be tolerated is selective pressures to keep conserved functions of
proteins with nonsynonymous changes. The nonsynonymous changes would be more likely to
replace similar amino acids that do not disrupt protein function, or in regions of the protein less
likely to disrupt function. Variants in this dataset that were predicted to be tolerated were
deemed less likely to be causative of the evolved resistance to MCHM.
The deleterious and NA scored variants all include variants that change the protein
sequences. A variant given a score of NA, or not applicable, was usually an indel variant that
could not be scored, but occasionally was a SNP variant that did not appear in the SIFT
database. Many of the deleterious and NA scored variants appear in proteins that are
uncharacterized or dubious ORFs (Supplemental File 1). The variants in PDR3 in all eight MCHM
ILEs received a score of NA. The only pattern of genes with these scores amongst the ILEs was
the PDR3 mutations. Other deleterious and NA scored mutations may provide unique effects on
MCHM resistance in individual strains but were not a consistent pathway to resistance in
different strains.
Table 3: Summary of predicted tolerance for coding variants found only in MCHM ILE strains.
The eight MCHM ILE strains are represented from left to right in columns. Each strain is
summarized for whether its coding variants are predicted to be tolerated, deleterious, or NA
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based on SIFT4G analysis. NA scores mean a classification as either tolerated or deleterious was
not possible to determine, or not applicable (NA). SIFT4G scores approaching 0 are expected to
alter protein function to be deleterious based on amino acid substitutions. The NA results are
usually due to the inability of SIFT to predict the effects of indels or occasionally SNPs that do
not appear in the SIFT database. Coding variants in this table exclude those in Ty regions.
MCHM ILE
Strain

S9

S10

S11

S12

S13

S14

S15

S16

Total Variants

54

63

43

53

59

64

53

45

Tolerated

38

41

30

35

42

30

31

23

Deleterious

7

2

5

2

8

12

6

4

NA

9

20

8

16

9

22

16

18

Comparison of MCHM evolved genes with genes appearing in other genomic datasets from
MCHM studies:
Previous work has been done to produce genomic datasets that implicate genes
involved in MCHM resistance mechanisms, so it hypothesized that some variants may target
these same genes to adapt to MCHM treatment. The list of 107 genes containing at least one
variant in an MCHM ILE strain was compared to a genetic screen of the BY4742 knockout
collection and transcriptomic dataset (Figure 4) (Ayers et al., 2020). There was little overlap
with the genetic screen (Figure 4A). This is not surprising, as the knockout screen selected for
mutants with reduced MCHM resistance, revealing genes that are required for resistance.
Therefore, in the 329 genes found from the previous knockout screen, any variants in evolved
strains would have to avoid reducing the function of the proteins produced by those ORFs, as
their existing function is known to be required for MCHM resistance. Adaptive changes to these

135

genes would most likely need to improve their current function in MCHM responses, which is
less likely than a mutation neutral or deleterious to protein function.
Yeast were treated with MCHM and the changes in gene expression were quantitated.
The transcriptomic dataset included a list of 592 upregulated genes and a list of 576
downregulated genes. There was more overlap with these lists and the 107 ILE genes, including
14 upregulated (Figure 4B) and eight downregulated genes (Figure 4C). The overlapping genes
in these cases include several of the genes with variants in many ILE strains. Some genes of
special note are the hexose transporters and carbon metabolism genes HXT11, MAL13, and
HXT17 from the upregulated list, and HXT7 from the downregulated list. HXT17 contains
variants unique to MCHM ILEs in five strains and did not accumulate more mutations in some of
the other ORFs containing dozens of mutations. Another gene involved in glucose metabolism
with the hexose transporters above is DOG1, which encodes a deoxyglucose phosphatase
involved in resistance to 2-deoxyglucose (Randez‐Gil et al., 1995; Sanz et al., 1994; Soncini et
al., 2020). While DOG1 is responsible for alleviating stress from toxic glucose analogs in yeast,
GEX2 encodes a glutathione transporter important for oxidative stress resistance, a known
source of stress from MCHM treatment (Ayers et al., 2020; Dhaoui et al., 2011). Carbon
metabolism and stress-responsive genes are not the only types of genes in the overlapping
datasets. Several cell wall proteins appear as well, including PIR3, TIR1, SCW10, and FLO1, each
with varying functions from cell wall stability (PIR3) to flocculation (FLO1) (Cappellaro et al.,
1998; Doolin et al., 2001; Hodgson et al., 1985; Kitagaki et al., 1997; Kowalski et al., 1995;
Rossouw et al., 2015; Teunissen & Steensma, 1995; Toh‐E et al., 1993; Yun et al., 1997). These
datasets continue to point to the cell wall and sugar metabolism as functions that are important
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ways to adapt resistance to MCHM. However, most of these genes also seem to accumulate
mutations in control strains as well (Supplemental File 2). This could be from the passages
themselves. The control yeast were also grown to saturation before being diluted into fresh
media. Any mutation that decreases the lag before growth would be advantageous in these
conditions, and these variants would begin to dominate the culture. These variants may have
occurred in the variant dataset only by chance or from other selective pressures and not due to
functional changes that contribute to MCHM resistance. Mutations in PDR3 and TPO2 were
detected in many MCHM ILEs, contain variants in no control ILEs, and are differentially
regulated at the transcriptome level in MCHM treated cells (Supplemental File 2 and Figure 4).
TPO2 belongs to a family of transporter proteins that are part of the multidrug resistance
pathway. The protein localizes to the plasma membrane and has been characterized as an
exporter of polyamines (Tomitori et al., 2001), which could be related to the amino acid
biosynthesis pathways implicated in MCHM resistance in previous work (Ayers et al., 2020).
However, the mutations in TPO2 are all synonymous (Supplemental File 1). The codon changes
could potentially affect protein levels if they affected translation rates.
Analysis of evolved alleles in PDR3:
The PDR3 variants in the MCHM ILEs showed a pattern of evolution that pointed to a
reproducible pathway to resistance. We decided to look more closely at the individual
mutations. Previous research has been done with PDR3 mutagenesis to produce gain-offunction alleles that improve resistance to different chemicals (Nourani et al., 1997). For
instance, amino acid mutations in the region from approximately residues 220-280 created
alleles that increased the expression of multiple ABC transporters that pump chemicals out of
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cells, specifically SNQ2 and PDR5 (Nourani et al., 1997). The mutations in PDR3 in the S12, S13,
and S15 ILEs mutated single amino acids at residues 288, 209, and 229 respectively (Figure 5A).
It is possible that these mutations are creating gain-of-function alleles that increase the
expression of ABC transporters, thereby conveying resistance to MCHM. The gene SNQ2 is
required for resistance to MCHM (Ayers et al., 2020), but it has yet to be shown if
overexpression would be sufficient to produce resistance.
The remaining five mutations resulted in changes to the C-terminal portion of the
protein, where an activation domain homologous to Gal4-like transcriptional activators is
located (Delaveau et al., 1994). The S9 mutation was a M842L single amino acid change (Figure
5A). One study produced six different gain-of-function mutations in this region with single
nucleotide changes that increased expression of PDR3, PDR5, and SNQ2 and conferred
resistance to several chemicals (Simonics et al., 2000). None of the mutations were the same as
found in the ILE strains, but they do implicate this region of the protein for possible gain-offunction resistance mutations. The S16 mutation was an insertion and frameshift occurring at
the amino acid 972 that altered and extended the remaining four amino acids into an extra nine
amino acids before the new stop codon (Figure 5A).
The S10 and S14 mutations truncated the protein by 415 and 406 amino acids,
respectively (Figure 5A). The S11 mutation also truncated the protein, but by 82 amino acids
(Figure 5A). One hypothesis is that deletions of this much of the protein sequence would
produce nonfunctional products, effectively acting as a knockout. Alternatively, these
truncations could still produce proteins with some function, considering the DNA binding
domain is at the N-terminus, like other Gal4-like transcription factors (Delaveau et al., 1994).
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Furthermore, the motifs implicated in the homo- and heterodimer interactions of Pdr3 and
Pdr1 are also in the N-terminal 400 amino acids. With dimerization and DNA interacting regions
of the protein products intact, the truncated alleles of S10, S11, and S14 could be functional
proteins.
To test the more fundamental hypothesis that a knockout-like truncation may confer resistance
to MCHM, we knocked the PDR3 gene out of the wildtype parent of the ILEs, YJM789. The
pdr3∆ strain produced by knocking out the gene with a NATR marker showed similar resistance
as the S11 resistant MCHM strain (Figure 5B). S11 corresponds to the strain containing the
shortest truncation of the Pdr3 protein, only 82 amino acids. If the mutations to PDR3 in the
evolved strains are mimicking a knockout by making Pdr3 nonfunctional, that would be
sufficient to produce the resistant phenotype. The pdr3∆ in the BY4742 strain background was
also tested for MCHM resistance to see if the relationship between this genotype and
phenotype was specific to the YJM789 background. At 2 days of growth, BY4742 pdr3∆ grew
faster than the BY4742 wildtype strain at 550ppm MCHM (Figure 5B). However, by three days,
the wildtype strain reached similar growth to the knockout (not shown), and the knockout did
not show a resistant phenotype above 550ppm MCHM. The knockout of this gene produced
some increased resistance, indicating its effects may be important outside of the YJM789
genetic background. The effect in YJM789 appears greater, producing a resistant phenotype at
concentrations much higher than the wildtype strain’s tolerance.
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Discussion
The In-Lab evolution of the YJM789 strain of S. cerevisiae produced thousands of
mutations in each strain. The mutations were similar in number from strain to strain, including
both control media and MCHM-treated conditions. MCHM is known to induce DNA damage
(Ayers et al., 2020), which could possibly be a mechanism for mutation, but as the control
strains accumulated similar numbers of mutations, it likely played little role other than a
selective pressure on mutations occurring normally in the growth conditions. There was no
clear pattern of mutations resulting in MCHM resistance across strains, though the sheer
number of mutations could mask any pattern with background variants. When filtered for
mutations unique to MCHM ILEs that were only found in coding sequences, patterns such as
cell wall and responses to stress did begin to emerge. These patterns are consistent with
previous knowledge of MCHM effects on cells, including oxidative stress activation (Ayers et al.,
2020). MCHM is also known to act as a hydrotrope (Pupo, Ayers, et al., 2019), so variants that
may stabilize the plasma membrane or cell wall could be likely resistance mechanisms. Despite
consistency with previous work, these patterns also have issues that reduced confidence that
they were causative variants. In particular, the variants included synonymous mutations and
genes that were accumulating mutations in control strains as well. Synonymous mutations do
not change protein sequence and are unlikely to significantly affect the function of that protein
unless altering expression levels. The plentiful mutations in the same genes in control strains
may indicate that the genes are hotspots for mutation accumulation, reducing the likelihood
any particular mutation was found due to selection for a competitive advantage in MCHM.
However, based on the QTL study previously done in MCHM, associative loci that failed to reach
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LOD score significance were spread relatively evenly throughout the genome (Pupo, Ayers, et
al., 2019). This indicates that the presence of small effect loci contributing to a combined
pleiotropic effect on resistance phenotype is likely. These variants may be contributing small
phenotypic effects even if they are not sufficient to produce resistance on their own.
There was only one gene that seemed to mutate exclusively in MCHM strains: PDR3. The
role of this gene in activating the stress response to chemicals, combined with it being the only
gene to mutate in every MCHM ILE but no control ILE, made it the most likely candidate for
reproducible evolved resistance to MCHM. Follow-up genetic work by knocking the gene out of
the original parent strain revealed that inactivating the protein was sufficient to induce
resistance at the level of the evolved strains. This gene is the first to be identified in yeast as a
target to induce resistance to MCHM. Previous work, such as the genetic screen, focused only
on finding genes required for tolerance. The screen was not designed to detect an increased
resistance phenotype in any of the mutants tested. The model for this resistance involves the
importance of Pdr3 in controlling the activation of multiple ABC transporters that pump stressinducing chemicals out of cells. Pdr3 and its paralog Pdr1 form homo- and heterodimers and
then bind to transcriptional response regions termed PDREs, where they can inhibit or activate
transcription of genes such as PDR5, SNQ2, YOR1, PDR15, PDR10, and other transporters
(Delaveau et al., 1994; Jungwirth & Kuchler, 2006; Katzmann et al., 1996; Kolaczkowski et al.,
1998; Mahé et al., 1996; Mamnun et al., 2002; Servos et al., 1993) (Figure 5C). Changing the
levels of functional Pdr3 or altering the ability of Pdr3 to dimerize could affect expression of
individual or multiple ABC transporters and change the amounts of ones more important for
MCHM resistance. We tested via knockout in the YJM789 parent strain if inactivating mutations
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could be sufficient to produce MCHM resistance. (Ayers et al., 2020; Pupo et al., 2019). The
mutations in PDR3 could also be activating mutations that make Pdr3 increase transcription of
all or some transporters, such as SNQ2 or PDR5.
The SNQ2 gene is required for MCHM resistance, so it is a likely candidate for this
increased expression (Ayers et al., 2020). There is a 637 amino acid N-terminal truncation in the
Snq2 protein in YJM789 as compared to the reference strain, or the resistant QTL parent strain
S96. The YJM789 allele of PDR5 is also divergent from the reference and S96 yeast strains, with
a 5.3% amino acid difference compared to the reference strain (Guan et al., 2010; Wei et al.,
2007). The YJM789 allele of PDR5 has been shown to alter the strain’s resistance to antifungals
(Guan et al., 2010), increasing or decreasing resistance depending on the chemical. PDR5 is not
required for resistance to MCHM like SNQ2 according to previous work, but this work was done
in the BY4742 strain, which has the same allele as the reference strain (Ayers et al., 2020). It is
possible that the YJM789 PDR5 allele can provide resistance to MCHM if the expression is
increased. PDR5 is significantly upregulated by gain-of-function mutations in PDR3 in the same
regions as the MCHM ILE variants (Nourani et al., 1997; Simonics et al., 2000), but changes in
expression of transporters in strains with mutated Pdr3 have not been measured. The divergent
allele complements of ABC transporters between YJM789 and S96 may also point to a possible
explanation for the lack of evolved resistance we observed in the S96 strain. While changes to
the function of Pdr3 may be a good target for evolved resistance in YJM789, the alleles of ABC
transporters in S96 may be less amenable to the PDR3 genotype-phenotype relationship. This
may also explain why the BY4742 strain seemed to receive a less extreme increase in resistance
from its pdr3∆ deletion, as BY4742 and S96 are closely related strains.
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This study was able to produce MCHM resistant evolved strains of YJM789. The patterns
from the evolved strains point most clearly to a model involving resistance via mutation of the
gene encoding the transcription factor Pdr3. Background mutations in the ILEs, such as less
consistently mutated genes or mutated cis-regulatory elements, may also be contributing to
resistance in each strain. In this case, resistance to MCHM might involve various pathways that
allow for a mix of small effect changes throughout the genome. This would be consistent with
work that has shown hundreds of required genes, hundreds of differentially regulated genes,
and a QTL showing widespread low effect loci throughout the genome (Ayers et al., 2020; Pupo,
Ayers, et al., 2019). Analysis of these types of small combinations of alleles will be difficult.
Therefore, future work should explore the hypotheses from the model that the PDR3 alleles in
the ILEs are sufficient to provide MCHM resistance by altering the expression of ABC
transporters. Cloning each allele into the YJM789 PDR3 knockout strain will create strains that
can test directly for MCHM resistance and test the altered expression of the ABC transporters in
the same genetic background, isolated from the background mutations of the ILE strains.
Quantitative PCR for all relevant genes, especially SNQ2 and PDR5, and western blots of the
protein products will answer whether these alleles change the expression of these genes. The
results of these experiments should reveal whether MCHM resistance can be evolved
reproducibly through one large effect gene, or if it is mainly acquired through many small
changes. The cloned alleles of PDR3 may also be relevant for studies of the transcription
factor’s role in other stress resistance mechanisms. Other future directions for this dataset
could explore hypotheses about TPO2 codon usage bias to determine if the evolved
synonymous allele changes contribute significantly to MCHM resistance. The dataset may also
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be informative of patterns of evolution in stress treatments when combined with ILE analysis in
other environments. Adaptive changes to MCHM provide insight into this specific novel
chemical stressor of yeast, but also inform studies about stress responses and evolution in the
field.
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Figures:

Figure 1: In-Lab evolutions produce MCHM resistant yeast strains. A. Four biological replicates
of YJM789 yeast were grown in liquid rich media (YPD) with and without 700ppm MCHM. Each
replicate was grown for two days, then passaged by inoculating 1% of the culture into fresh
media. Six total passages were done, testing growth by serial diluting the cultures onto solid
media containing 1000ppm MCHM to determine that resistance was achieved. Resistant
isolates were passaged on solid rich media plates without MCHM to check for loss of
epigenetically inherited resistance mechanism. Two single colony isolates from each of the four
control and four MCHM replicates were selected for analysis. Genomic DNA was extracted and
sequenced with Illumina. B. Resistance of isolates from the In-Lab evolutions were examined by
serial dilution assay on solid YPD with and without 1000ppm MCHM. The eight control strains
are labeled S1-S8. Pairs of strains (S1 and S2, S3 and S4, etc.) are isolates from the same original
biological replicate. Pairs were plated on the same plates with a control YJM789 parent strain
for growth assays. The YJM789 parent appears on each plate to control for plate to plate
variation in MCHM dosage due to volatility and the high concentration of MCHM approaching
its limits. The eight MCHM evolved strains are labeled S9-S16, and pairs such as S9 and S10 are
isolates from the same biological replicate.
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Figure 2: PCA analysis of evolved variants in In-Lab evolution strains according to resistance
phenotype. The 6874 variants found in the control and MCHM strains after sequencing,
aligning to the reference yeast genome, and filtering of existing variants in the YJM789 parent
genome were considered to constitute the entirety of variants produced through the In-Lab
evolution passaging experiment. There were approximate 2500 variants per strain, and many
variants appeared in more than one strain. The 16 strains were clustered by PCA analysis
according to their variant content. Strains are colored by their resistance phenotype, with the
eight control strains in red and the eight MCHM resistant strains in blue. Samples are also
labeled S1-S16 corresponding to strain names from Figure 1. The first three principal
components are plotted against each other as follows: A. principal component 1 vs principal
component 2, B. principal component 1 vs. principal component 3, and C. principal component
2 vs. principal component 3.
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Figure 3: Intersection and functional analysis of genes containing variants in the MCHM
evolved strains. A. Variants were filtered for their presence in coding sequences and for their
presence exclusively in MCHM evolved strains. The variants from this list that resulted in
nonsynonymous changes were found in 75 genes. Each of the eight MCHM strains contained
nonsynonymous variants in between 15 and 23 genes, so there was some overlap in genes
between strains. The intersection of the genes between the strains was analyzed by UpSetR.
The bar graph vertical axis shows the intersection size, or the number of genes present in each
intersection. The definition of each intersection appears in the filled and connected ovals below
each bar. The eight strains are organized from smallest to largest (top to bottom) number of
genes (set size) on the left. B. A similar set of genes as in part A, but containing both
synonymous and nonsynonymous variants, consisting of 107 genes containing coding variants
for the MCHM strains. These genes were analyzed for function, process, and cellular
component terms. The GO Term and the False Discovery Rate (FDR) for each term is shown on
the yeast cell diagram. FDR is represented as percentages, not ratios.
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Figure 4: Venn diagrams show overlap between the genes with variants in MCHM evolved
strains with genes in other MCHM genomic datasets. A. This Venn diagram shows the overlap
of the gene lists from the MCHM evolution strains (ILE Variant Genes) and the genetic screen of
the BY4742 strain knockout collection showing genes required for MCHM resistance (knockout
screen genes) (Ayers et al., 2020). The number of genes found only in each list and in the
overlap are shown in the diagram. The one gene in the overlap of the lists is written below the
diagram. B. This Venn Diagram shows the overlap of the MCHM evolution strains genes and the
upregulated genes from a transcriptome of MCHM treated BY4741 strain (Ayers et al., 2020).
The 14 genes in the overlap of the datasets are listed below the diagram. C. This Venn Diagram
shows the overlap of the MCHM evolution strains genes and the downregulated genes from the
same transcriptomic analysis as B. The eight genes in the overlap of the datasets are listed
below the diagram.
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Figure 5: Pdr3 alleles in the MCHM evolved strains and how the pleiotropic drug response
transporters are genetically controlled by Pdr1 and Pdr3. A. The eight MCHM evolved strains
each contained exactly one mutation in the PDR3 gene, all of which created protein sequence
changes. The alleles are diagrammed alongside the wildtype YJM789 allele. The names of each
strain are the left of each allele. The Zn Finger DNA-binding domain and Gal4-like Activation
Domains are highlighted with green boxes in the N-terminal and C-terminal regions,
respectively. The residue number for the start of each of the eight mutations is at the bottom of
the diagram. Single letter amino acid abbreviations are used to indicate the identity of the
residues in the parental allele. Each of the evolved strains (S9-S16) have exactly one mutation,
so S9, S12, S13, and S15 show their single residue changes from the parent. The S10, S11, and
S14 strains have early stop codons shown by a slash and dashed line where the missing portion
of the protein coding sequence will not be translated. The final strain, S16, contains an insertion
that alters the last five amino acids of the protein to a new 13 amino acid sequence. B. Shown
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are serial dilution growth assays of one of the evolved resistant strains (S11), the YJM789
parent strain, the YJM789 PDR3 knockout strain, the BY4742 wildtype strain, and BY4742 PDR3
knockout. The growth assays are on increasing concentrations of MCHM from 0ppm (YPD) to
1000ppm. The day pictures were taken is shown underneath assays, day two or three shown
for lower and higher concentrations of MCHM respectively to exemplify growth differences. C.
This diagram models how Pdr1 and Pdr3 transcription factors control the expression of ABC
transporters involved in the export of chemicals in response to stress. As cells are exposed to
drugs, the transcription factor dimerizes, which results in binding to cis-regulatory elements
called PDREs upstream of genes encoding various ABC transporters. The major ABC and hexose
transporters (Pdr5, Snq2, etc.) contain PDREs bound by Pdr1 and Pdr3 are shown in the plasma
membrane and labeled.
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Supplemental Figure 1: Variant density plot of 6874 variants across the 16 evolved strains. A.
The 6874 variants remaining after removing variants shared by all 16 strains and known YJM789
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SNPs were plotted on the yeast genome. All instances of each variant in each strain were
plotted, so approximately 40000 variants were plotted in total, as many remaining variants
were shared by upwards of 10 strains each. Each chromosome is represented as a bar, with
base pair locations labeled every 100kb. The variants are plotted as a density curve using 2.5kb
windows along the top of each chromosome. B. The variants were filtered to only those shared
among less than 10 strains, leaving 4968 individual variants. This translated to approximately
15000 instances of these variants across the 16 strains, which were then plotted on the yeast
genome. Each chromosome is represented as a bar, with base pair locations labeled every
100kb. The variants are plotted as a density curve using 2.5kb windows along the top of each
chromosome.
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Supplemental Figure 2: Intersection of genes containing synonymous and nonsynonymous
variants in the MCHM evolved strains. Variants were filtered for their presence in coding
sequences and for their presence exclusively in MCHM evolved strains, as in Figure 2. The
variants from this list that resulted in synonymous and nonsynonymous changes were found in
107 genes. The intersection of the genes between the strains was analyzed by UpSetR. The bar
graph vertical axis shows the intersection size, or the number of genes present in each
intersection. The definition of each intersection appears in the filled and connected ovals below
each bar. The eight strains are organized from smallest to largest (top to bottom) number of
genes (set size) on the left.
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The following Supplemental Material is available at
https://github.com/wvumayers/MCHM.git.
Supplemental File 1: Tables of coding variants in each evolved MCHM strain. This file contains
eight tabs, each with one of the eight MCHM evolved strains labeled S9 through S16. Each tab
contains all the variants found in the coding regions of each strain, and its accompanying
information. This includes the location of the variant, identity of the gene containing the
variant, the nucleotide allele change from the variant, the coding consequence change from the
variant, and a prediction using SIFT as to whether the mutation is tolerable or deleterious to
protein function.
Supplemental File 2: Matrix of all mutations in 107 genes identified as containing unique
variants in MCHM strains. The 107 genes that were identified as having unique variants in
MCHM evolved strains did not necessarily have no variants at all in control strains. Therefore, a
matrix was created using coding analysis in all 16 strains for these 107 genes. All synonymous
and nonsynonymous changes are included in the analysis. The number of variants in each gene
in each strain is shown, with summary columns to the right. These columns identify how many
control and MCHM strains have at least one variant and the total number of variants contained
in control and MCHM strains. Those genes with variants present in between one and three
control strains are colored yellow, while those with zero variants in control strains are labeled
red in the summary columns. Those genes with variants in greater than three MCHM evolved
strains are labeled in green. The intersection of these two summaries (genes with variants in
very few control strains but in many MCHM strains) helped identify PDR3 as the only gene with
mutations in all MCHM strains and no control strains.
Supplemental Table 1: R packages used to perform variant analysis. This table contains the
identity of all R packages that were used, including dependencies, in the analysis of variants for
annotation and coding prediction. The package is listed with its version used. The citation for
each package is also included in the third and successive columns.
Supplemental Table 2: List of 107 genes containing unique variants in MCHM evolved strains.
This list includes all genes that contain a unique variant that results in either synonymous or
nonsynonymous changes to the protein. This list was used for the GO term analysis in Figure 3,
the Venn diagrams in Figure 4, and the intersection graph in Supplemental Figure 2.
Supplemental Table 3: List of 75 genes containing unique variants causing nonsynonymous
changes in MCHM evolved strains. This list includes all genes that contain a unique variant that
results in only nonsynonymous changes to the protein. This list was used for the intersection
graph in Figure 3.
Supplemental Table 4: Matrix table of all 6874 variants and their presence or absence in all 16
strains. This table uses a matrix containing binary values of 1 meaning presence of a variant in a
strain and 0 meaning absence. Variant identity is described explicitly in the first column with S.
cerevisiae chromosome reference id, bp location, and allele change shown. Columns 2 through
4 summarize the location of the variant using chromosome, start bp location, and stop bp
location.
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Chapter 6: CONCLUSION
The study of the chemical 4-methylcyclohexanemethanol following it spilling into the Elk
River in January 2014 initially focused on its physical and toxicological properties. As
summarized in Chapter 2, this chemical was relatively uncharacterized for any biological effects,
so immediate work focused on determining any health outcome effects. The National
Toxicology Program ran a battery of studies and came to the conclusion that, while MCHM and
components of the spill could have developmental impacts such as reduced birth weight in
rodents and skeletal changes in fish, and while it could cause neurological effects based on fish
photomotor responses, neither of these outcomes occurred in concentrations simulating the
levels found in the spill (West Virginia Chemical Spill: Collective NTP Findings and Supporting
Files, n.d.). Follow-up analyses of real birth weight outcomes in the impacted region in the
aftermath of the spill also showed no noticeable changes (Benson et al., 2018). There remained
open questions about how MCHM impacted cell biology, which this dissertation sought to
address. This dissertation explored the relationship between genotype and resistance
phenotype for MCHM in yeast.
The data shown in Chapter 3 reveals that the way MCHM initially impacts yeast cells is
by very quickly causing cell cycle arrest in G1. The chemical stress does not kill the cells because
they successfully respond with a pre-programmed cellular network called the environmental
stress response. This is confirmed by the transcriptome data that identified downregulation of
ribosome biogenesis genes and upregulation of stress genes involved in the pleiotropic drug
response, oxidative stress response, and metal and ion homeostasis. The source of the MCHMinduced stress that activates the ESR in this way is likely to be nutrient deprivation. The genetic
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screen of the BY4742 knockout collection showed the requirement of aromatic amino acid
biosynthetic genes ARO1, ARO3, TRP2, TRP3, TRP4, and TRP5, all of which were also
upregulated in the wildtype transcriptome data. While supplementation of tryptophan,
tyrosine, and phenylalanine was not sufficient to rescue growth phenotypes in MCHM, it is
possible these end products cannot prevent the arrest that impacts growth on MCHM and are
more important to resume growth after cells adapt to the stress. Other metabolites in the
aromatic amino acid and trp pathways, such as chorismate and indoles, may also be important
instead of or in combination with the amino acid products. Finally, the proteins themselves may
have unannotated functions other than amino acid biosynthesis. Knockouts of TRP2 in
particular have been shown to grow poorly even with tryptophan supplementation, which
rescues other trp mutants (Krömer et al., 2013).
The nutrient deprivation signal is a likely cause of the early activation of cell cycle arrest
and ESR programming in yeast, but MCHM also induces reactive oxygen species over longer
time courses. After 6 and 12hrs, MCHM produces ROS, as detected by flow cytometry in
Chapter 3. A consequence of the production of ROS in the cell can be DNA damage, which was
suggested as a consequence of MCHM + S9 treatment based on expression of DNA damage
response proteins like Rad51 in the earliest yeast study on MCHM (Lan et al., 2015). The comet
assay in the Chapter 3 shows that DNA damage is a result of MCHM treatment of yeast. The
ROS and resulting DNA damage stresses are key consequences of MCHM exposure in yeast,
though they are unlikely to cause the initial cell cycle arrest and environmental stress response
programming. Instead, they may be a result of the cell’s metabolism of MCHM over time. We
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propose that once the cell has metabolized and overcome any concomitant stress induced by
the metabolites, it resumes growth and the cell cycle.
The ability for the cell to overcome the ROS and related stresses from MCHM is
dependent on the cell’s ability to respond to ion, metal, and ROS homeostasis. The
transcriptome of Chapter 3 points to mitochondrial genes and the vacuolar ATPase, which are
important to these pathways, but Chapter 4 provides the evidence that confirms their roles.
Petite yeast, missing functional mitochondria, are sensitive to ROS and metal stressors (Grant et
al., 1997), so their sensitivity to MCHM is as predicted. The QTL experiment of MCHM growth in
the YJM789xS96 yeast segregant collection pointed to loci spread broadly throughout the
genome with only one peak able to pass statistical significance. This peak was above a gene for
the protein Yke4, a zinc transporter in the ER. The levels of zinc increase with MCHM in
resistant grande yeast and the BY4741 strain knockout for YKE4 is sensitive, but growth is
rescued with supplementation of low amounts of zinc to the growth media. The simplest
explanation points to increased levels of zinc for resistance, but the sensitive parent in the QTL
has significantly higher intrinsic levels of zinc. As higher levels of zinc supplementation fail to
rescue MCHM growth, it seems that it is a more complicated role in the tight control of zinc
levels in the cell that affect resistance. MCHM acts as a hydrotrope, affecting the solubility of
proteins in vitro and reducing aggregation to 60% of no treatment in the aggregation assay of
Chapter 4. Zinc treatment increases aggregation in the same assay. The intracellular and
extracellular loop domains of transmembrane transporters such as Yke4 have disordered
regions that may be affected by this solubility effect. In this way, MCHM can affect the ability of
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the cell to control intracellular and compartmental levels of nutrients. The tight control of zinc
levels may work in vivo to allow cells to adapt to hydrotrope effects of MCHM.
The study of genotypes related to MCHM resistance in the genetic screen of Chapter 3
and the QTL of Chapter 4 was continued with an In-Lab evolution experiment in Chapter 5. The
QTL resistant parent strain S96 was unable to produce an evolved strain with improved
resistant via ILE over several attempts. The evolution of the sensitive QTL parent strain YJM789
produced eight resistant strains. Variant analysis of these strains and eight control strains
evolved similarly, but without MCHM, showed thousands of mutations spread broadly
throughout the genome in all strains. There was no clear pattern according to clustering
analysis of these mutations for resistance phenotype. In agreement with the peaks of the QTL
in Chapter 4 that did not reach significance, the variants spread broadly throughout the
genome point to resistance to MCHM involving small contributions of many cellular pathways
and networks to produce the single complex phenotype. However, the ILEs did point to one
gene in particular that may be a large determinant of MCHM resistance. The gene PDR3 had a
mutation in every strain that became resistant to MCHM and none in any of the control strains.
This was the only gene to have this profile. Every other gene that had mutations in the resistant
strains also contained mutations in the control strains. The PDR3 mutations resulted in protein
sequence changes, including four with single amino acid changes, three with C-terminal
truncations, and one with an insertion changing the five C-terminal amino acids to a new 13
amino acid terminus. The effects of these eight new alleles on resistance mechanisms are still
under investigation, but the gene knockout in the YJM789 parent strain is sufficient to produce
resistance similar to the evolved strains. The PDR3 gene is a nominal target for gain-of-function
171

resistant genotypes due to its role in controlling the expression of ABC transporters that pump
chemical stressors out of the cell. In retrospect the importance of PDR3 mutations in the
induction of new resistance phenotypes may also point to why the resistant parent strain S96
was unable to easily produce evolved resistance. While the wildtype transcription factor shows
few mutations between strains, several ABC transporter genes whose expression is controlled
by Pdr3 are polymorphic between the strains. There is a large 637 amino acid truncation in the
N-terminus of Snq2 in the YJM789 strain and a 5.3% amino acid divergence spread throughout
the protein of Pdr5 between the two strains (Wei et al., 2007). Differences in ABC transporter
complements may have prevented the large-scale changes that induced resistance in YJM789
from being replicated. Indeed, while a knockout of PDR3 in the BY4742 strain, which is closely
related to S96, did produce some increased resistance, it was not sufficient to produce
resistance beyond 550ppm exposure.
The role of genotypes in creating stress response phenotypes was explored in this
dissertation using the toxicologically-relevant spill chemical MCHM. We found that wildtype
yeast strains exhibit MCHM tolerance that requires aromatic amino acid biosynthetic genes,
redox stress responsive genes, mitochondrial genes, and metal and ion homeostatic genes to
mitigate nutrient, ROS, and protein folding stress from the hydrotrope nature of the chemical.
These many sources of stress rely on pathways and networks within the cell that are impacted
by loci spread broadly throughout the genome, as seen through QTL, screen, and ILE analyses.
This study was able to identify only one locus where the genotype could produce an increased
resistant phenotype beyond wildtype levels, the transcription factor controlling expression of
multiple drug transporters. Stress responsive phenotypes are controlled by many important
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small effect loci, but some individual loci may provide outsize effect on chemical sources of
stress.
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